,drug_name,section_name,gpt_output
0,XEOMIN,adverse reactions,"Hypersensitivity, Dysphagia, Breathing Difficulties, Spread of Effects from Toxin, Neck pain, Muscle weakness, Injection site pain, Musculoskeletal pain, Eyelid ptosis, Dry eye, Dry mouth, Diarrhea, Headache, Visual impairment, Dyspnea, Nasopharyngitis, Respiratory tract infection, Facial paresis, Injection site hematoma, Eyelid edema, Eye swelling, Nausea, Flu-like symptoms, Injection site reaction, Allergic dermatitis, Localized allergic reactions, Swelling, Edema, Erythema, Pruritus, Rash, Herpes zoster, Muscle spasm, Dysarthria, Myalgia"
1,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, swallowing difficulties, death"
2,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, clinical effects of treatment, dysphagia risk in smaller neck muscle mass, dysphagia risk in bilateral injections into the sternocleidomastoid muscles, corneal exposure, corneal ulceration, reduced blinking, corneal exposure with possible ulceration or perforation, diplopia, ptosis, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death related to the spread of toxin effects, hypersensitivity reactions, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, swallowing difficulties, breathing difficulties, severe dysphagia, aspiration, critical loss of breathing capacity, respiratory failure, severe dysphagia, respiratory compromise, persistent epithelial defect, ectropion, narrow angle glaucoma, ecchymosis"
3,QUTENZA,adverse reactions,"Application-Associated Pain, Increase in Blood Pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
4,QUTENZA,warnings and precautions,"coughing, sneezing, irritation of eyes, irritation of airway, transient increases in blood pressure, procedural pain, acute pain, increases in blood pressure, adverse cardiovascular effects"
5,ZYTIGA,adverse reactions,"Hypertension, Hypokalemia, Fluid Retention, Adrenocortical Insufficiency, Hepatotoxicity, fatigue, joint swelling or discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, Muscle discomfort, Dyspepsia, Upper respiratory tract infection, Urinary frequency, Nocturia, Fractures, Arrhythmia, Chest pain or chest discomfort, Cardiac failure, Pyrexia, Groin pain, Constipation, Insomnia, Falls, Nasopharyngitis, Hematuria, Rash, Hypernatremia, non-infectious pneumonitis, myopathy, rhabdomyolysis."
6,ZYTIGA,warnings and precautions,"Mineralocorticoid excess, cardiovascular disease, LVEF < 50%, NYHA Class III or IV heart failure, LVEF < 50%, NYHA Class II to IV heart failure, hypertension, hypokalemia, fluid retention, grade 3 to 4 hypertension, grade 3 to 4 hypokalemia, grade 3 to 4 edema, heart failure, recent myocardial infarction, ventricular arrhythmia, Adrenocortical insufficiency, adrenal insufficiency, interruption of daily steroids, concurrent infection, stress, Hepatotoxicity, grade 3 or 4 ALT or AST increases, liver test elevation, liver enzyme increases, serum transaminases (ALT and AST) increases, bilirubin levels increases, moderate hepatic impairment, AST or ALT rise above five times the ULN, bilirubin rises above three times the ULN, AST or ALT greater than or equal to 20* ULN, bilirubin greater than or equal to 10* ULN"
7,TOVIAZ,adverse reactions,"dry mouth, constipation, angina, chest pain, gastroenteritis, QT prolongation on ECG, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus"
8,TOVIAZ,warnings and precautions,"Angioedema of the face, lips, tongue, and/or larynx, urinary retention, severe constipation, headache, dizziness, somnolence"
9,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, Ocular icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, Skin discoloration, AST elevation, ALT elevation, Amylase elevation, Creatine Kinase elevation, Hematuria, Proteinuria, serum creatinine increase, estimated creatinine clearance decrease, bone fractures, allergic reaction, angioedema, lactic acidosis, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rash, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia"
10,STRIBILD,boxed warnings,"Lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B"
11,STRIBILD,warnings and precautions,"new onset or worsening renal impairment, acute renal failure, Fanconi syndrome, lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B, liver decompensation, liver failure, renal impairment, proximal renal tubular dysfunction, bone pain, pain in extremities, fractures, muscular pain, weakness, increased serum creatinine, bone mineral density decreases, increased bone turnover, higher serum parathyroid hormone levels, higher 1.25 Vitamin D levels, osteomalacia, arthralgias, muscle pain, hypophosphatemia, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", immune reconstitution syndrome, inflammatory response to indolent or residual opportunistic infections, autoimmune disorders (such as Graves' disease, polymyositis, Guillain-Barre syndrome)"
12,FARXIGA,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, female genital mycotic infections, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, angioedema, urticaria, hypersensitivity, anaphylactic reactions, severe cutaneous adverse reactions, increases in hematocrit, increases in serum inorganic phosphorus, hyperphosphatemia"
13,FARXIGA,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer"
14,VICTRELIS,adverse reactions,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, dry mouth, diarrhea, vomiting, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma"
15,VICTRELIS,warnings and precautions,"birth defects, fetal death, anemia, decrease in hemoglobin concentrations, neutropenia, worsening of neutropenia, hypersensitivity reactions, urticaria, angioedema, dyspnea, exertional dyspnea, dizziness, syncope, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, pancytopenia, severe or life-threatening infections, life-threatening neutropenia"
16,VIMIZIM,adverse reactions,"Anaphylaxis and hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue"
17,VIMIZIM,boxed warnings,"anaphylactic reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, serious acute exacerbation of respiratory compromise, hypersensitivity reactions"
18,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, acute respiratory complications, sleep apnea, spinal or cervical cord compression (SCC), back pain, paralysis of limbs, urinary incontinence, fecal incontinence"
19,BEPREVE,adverse reactions,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, swelling of tongue, swelling of throat"
20,BEPREVE,warnings and precautions,"contact lens-related irritation, contamination, red eye"
21,PRISTIQ,adverse reactions,"Hypersensitivity, Suicidal Thoughts and Behaviors in Adolescents and Young Adults, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, Blood pressure increased, Dry mouth, Vomiting, Fatigue, Chills, Feeling jittery, Tremor, Disturbance in attention, Insomnia, Nervousness, Abnormal dreams, Urinary hesitation, Yawning, Vision blurred, Mydriasis, Vertigo, Tinnitus, Dysgeusia, Hot flush, Anorgasmia, Libido decreased, Orgasm abnormal, Ejaculation delayed, Erectile dysfunction, Ejaculation disorder, Ejaculation failure, Sexual dysfunction, Tachycardia, Asthenia, Weight increased, liver function test abnormal, blood prolactin increased, Musculoskeletal stiffness, Syncope, convulsion, dystonia, Depersonalization, bruxism, Urinary retention, Rash, alopecia, photosensitivity reaction, angioedema, ischemic cardiac adverse reactions, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, Lipids abnormalities, Proteinuria, Sustained hypertension, Orthostatic hypotension, Stevens-Johnson syndrome."
22,PRISTIQ,boxed warnings,"SUICIDAL THOUGHTS AND BEHAVIORS, increased risk of suicidal thoughts and behavior in children, adolescents, and young adults, worsening, emergence of suicidal thoughts and behaviors"
23,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, worsening of depression, emergence of suicidal ideation and behavior, suicidality, unusual changes in behavior, suicidal thinking and behavior, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, mental status changes, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, gastrointestinal symptoms, nausea, vomiting, diarrhea, sustained blood pressure increases, ecchymosis, hematoma, epistaxis, petechiae, hemorrhages, dizziness, nausea, headache, irritability, insomnia, diarrhea, anxiety, fatigue, abnormal dreams, hyperhidrosis, dysphoric mood, sensory disturbances, paresthesia, confusion, lethargy, emotional lability, tinnitus, headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, seizure, coma, respiratory arrest, death, progressive dyspnea, cough, chest discomfort."
24,TAFINLAR,adverse reactions,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, myalgia, cuSCC, cough, constipation, nasopharyngitis, hypophosphatemia, increased alkaline phosphatase, hyponatremia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, increased GGT, hypoalbuminemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT Prolongation"
25,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, New primary malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, KRAS mutation-positive pancreatic adenocarcinoma, recurrent NRAS mutation-positive colorectal carcinoma, head and neck carcinoma, glioblastoma, major hemorrhages, intracranial hemorrhage, gastric hemorrhage, deep venous thrombosis, pulmonary embolism, Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, fever, hypotension, rigors or chills, dehydration, renal failure, severe skin toxicity, secondary infections of the skin, hemolytic anemia"
26,MULTAQ,adverse reactions,"New or worsening heart failure, Liver Injury, Pulmonary toxicity, Hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rashes (generalized, macular, maculo-papular, erythematous), pruritus, eczema, dermatitis, dermatitis allergic, Photosensitivity reaction, dysgeusia, increases in creatinine >=10%, QTc prolonged, Atrial flutter with 1:1 atrioventricular conduction, Interstitial lung disease, pneumonitis, pulmonary fibrosis, Anaphylactic reactions, angioedema, Vasculitis, leukocytoclastic vasculitis"
27,MULTAQ,boxed warnings,"INCREASED RISK OF DEATH, STROKE, HEART FAILURE, doubles the risk of death, hospitalization for heart failure"
28,MULTAQ,warnings and precautions,"cardiovascular death, heart failure, increased risk of stroke, new onset or worsening heart failure, hepatocellular liver injury, acute liver failure requiring transplant, interstitial lung disease, pneumonitis, pulmonary fibrosis, dyspnea, non-productive cough, hypokalemia, hypomagnesemia, QT interval prolongation, marked increase in serum creatinine, pre-renal azotemia, acute renal failure, small increases in creatinine levels"
29,TANZEUM,adverse reactions,"Risk of Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity Reactions, Renal Impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, documented symptomatic hypoglycemia, severe hypoglycemia, pneumonia, atrial fibrillation, atrial flutter, appendicitis, anti-albiglutide antibodies, anti-GLP-1 antibodies, antibodies to human albumin, alanine aminotransferase (ALT) increase, gamma glutamyltransferase (GGT) increase, heart rate increase"
30,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
31,TANZEUM,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, acute pancreatitis, persistent severe abdominal pain, vomiting, serious hypersensitivity reaction with pruritus, rash, dyspnea, acute renal failure, worsening of chronic renal failure, nausea, vomiting, diarrhea, dehydration"
32,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, Constipation, Diarrhea, Dyspnea, Rash, Peripheral Edema, Cough, Thrombocytopenia, Pruritus, Chills, Increased Blood Lactate Dehydrogenase, Decreased Appetite, Headache, Infusion Site Pain, Hypokalemia, Prolonged QT, Abdominal pain, Hypotension, Phlebitis, Dizziness, pneumonia, increased creatinine, multi-organ failure, hepatic failure, ventricular fibrillation, febrile neutropenia"
33,BELEODAQ,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, serious infections, fatal infections, pneumonia, sepsis, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, nausea, vomiting, diarrhea, embryo-fetal toxicity, fetal harm, teratogenicity, embryo-fetal lethality"
34,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus"
35,HALAVEN,warnings and precautions,"Neutropenia, Peripheral Neuropathy, Embryo-Fetal Toxicity, QT Prolongation, Severe neutropenia, Grade 4 neutropenia, febrile neutropenia, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, Neuropathy lasting more than one year, new or worsening neuropathy, Embryo-fetal toxicity, teratogenicity, QT prolongation observed on Day 8, QT prolongation observed on Day 1, congestive heart failure, bradyarrhythmias, hypokalemia, hypomagnesemia"
36,XIAFLEX,adverse reactions,"Tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, pruritus, lymphadenopathy, axillary mass, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, injection site swelling, ecchymosis, penile ecchymoses, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, severe injection site hematoma, penile ""popping"" sounds or sensations."
37,XIAFLEX,boxed warnings,"corporal rupture (penile fracture), penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma"
38,XIAFLEX,warnings and precautions,"tendon rupture, serious injury to the injected finger/hand, possible permanent injury, tendon rupture, ligament damage, skin laceration, corporal rupture (penile fracture), serious injury to the penis, possible permanent injury, hypersensitivity reactions, anaphylaxis, abnormal coagulation, flexor tendon ruptures, damage to structures of the hand, tendon rupture, ligament damage, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin laceration (tear), skin laceration requiring skin graft, corporal rupture, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma, allergic reactions (pruritus), IgE-anti-drug antibodies, ecchymosis/contusion, injection site hemorrhage, penile hematoma, penile ecchymosis"
39,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, Serious Infections, Malignancies, Heart Failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, Anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, Angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, Optic neuritis, retinal hemorrhage, uveitis, Bleeding, injection site reactions, Elevated liver enzymes, hepatitis, Alopecia totalis, Anxiety, bipolar disorder, suicide attempt, Nephrotic syndrome, renal failure, Menstrual disorder, Dermatitis, erythema nodosum, Thrombophlebitis, vasculitis, Headache, Hypertension, Back pain, Pharyngitis, Acute bronchitis, Fatigue, herpes infections, lower respiratory tract infections, cellulitis, pyelonephritis, new or worsening heart failure, lupus-like syndrome, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis"
40,CIMZIA,boxed warnings,"serious infections, hospitalization, death, Active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, Invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, disseminated disease, localized disease, Bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria, tuberculosis, bacterial sepsis, Lymphoma, malignancies, fatal"
41,CIMZIA,warnings and precautions,"serious infections, invasive fungal infections, lymphoma, other malignancies, heart failure, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, tuberculosis, opportunistic infections including aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, worsening congestive heart failure (CHF), new onset CHF, hypersensitivity reactions including angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, hepatosplenic T-cell lymphoma (HSTCL), acute and chronic leukemia, neurological disorders including seizure disorder, optic neuritis, peripheral neuropathy, aplastic anemia, leukopenia, thrombocytopenia, blood dyscrasias, infection signs (e.g., persistent fever, bruising, bleeding, pallor)"
42,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Use in Patients with Sickle Cell Disease, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia"
43,GRANIX,warnings and precautions,"Splenic Rupture, Acute Respiratory Distress Syndrome (ARDS), allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, Sickle cell crisis, Capillary Leak Syndrome (CLS), hypotension, hypoalbuminemia, edema, hemoconcentration, anaphylaxis, Tumor Growth Stimulatory Effects on Malignant Cells"
44,TUDORZA,adverse reactions,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate Hypersensitivity Reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
45,TUDORZA,warnings and precautions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, angioedema, bronchospasm, anaphylaxis, swelling of the lips, tongue, or throat, urticaria, rash, itching, eye pain or discomfort, blurred vision, visual halos, colored images, red eyes from conjunctival congestion, corneal edema, difficulty passing urine, painful urination"
46,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, Arrhythmia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, sepsis, septic shock, increased AST, increased ALT, increased bilirubin, Gastritis, intestinal obstruction"
47,JEVTANA,boxed warnings,"neutropenic deaths, neutropenia, generalized rash/erythema, hypotension, bronchospasm"
48,JEVTANA,warnings and precautions,"Bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, anemia, thrombocytopenia, pancytopenia, neutropenic deaths, fatal infectious adverse events, sepsis, septic shock, Grade 3-4 neutropenia, hypersensitivity reactions, generalized rash/erythema, hypotension, bronchospasm, severe hypersensitivity reactions, nausea, vomiting, severe diarrhea, diarrhea related mortality, electrolyte imbalance, gastrointestinal hemorrhage, gastrointestinal perforation, ileus, enterocolitis, neutropenic enterocolitis, fatal outcome, abdominal pain, tenderness, fever, persistent constipation, renal failure, obstructive uropathy, deaths due to renal failure, fetal harm, embryotoxic, fetotoxic, abortifacient."
49,ILARIS,adverse reactions,"infections, upper respiratory tract infections, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, infections and infestations, gastrointestinal disorders, skin and subcutaneous tissue disorders, hypersensitivity reactions, decreased white blood cells, neutrophils, platelets, decreased white blood cell counts, transient decreases in absolute neutrophil count, mild and transient decreases in platelet counts, elevations of transaminases, high ALT and/or AST, asymptomatic and mild elevations of serum bilirubin"
50,ILARIS,warnings and precautions,"increased risk of serious infections, infections, recurring infections, predispose them to infections, serious infection, upper respiratory tract infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, serious infections associated with TNF inhibitors, new tuberculosis, reactivation of latent tuberculosis, opportunistic infections, malignancies, hypersensitivity reactions, anaphylactic reactions, immunosuppression, Macrophage Activation Syndrome (MAS)"
51,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, treatment emergent adverse events leading to discontinuation, confusional state"
52,AMPYRA,warnings and precautions,"seizures, anaphylaxis, respiratory compromise, urticaria, angioedema of the throat and or tongue, urinary tract infections"
53,SIRTURO,adverse reactions,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, Anorexia, Transaminases Increased, Rash, Blood Amylase Increased, alanine aminotransferase or aspartate aminotransferase greater than or equal to 3 times the upper limit of normal"
54,SIRTURO,boxed warnings,"Increased mortality, QT prolongation, significant ventricular arrhythmia, QTcF interval >500 ms"
55,SIRTURO,warnings and precautions,"QT prolongation, significant ventricular arrhythmia, QTcF interval > 500 ms, Hepatotoxicity, liver injury, increased risk of death, death, QT interval prolongation, ventricular arrhythmias, myocardial infarction, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, serum calcium below lower limits of normal, serum magnesium below lower limits of normal, serum potassium below lower limits of normal, Clinically significant ventricular arrhythmia, QTcF interval of greater than 500 ms, syncope, hepatic-related adverse reactions, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations, total bilirubin elevation greater than two times the upper limit of normal, aminotransferase elevations greater than eight times the upper limit of normal, aminotransferase elevations greater than five times the upper limit of normal."
56,ADREVIEW,adverse reactions,"serious hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
57,ADREVIEW,warnings and precautions,"Hypersensitivity reactions, anaphylactic and hypersensitivity treatment measures, serious reactions in premature or low birth-weight infants, increased radiation exposure, decreased quality of AdreView images, iodine 123 accumulation in the thyroid, unreliable imaging results, clinically significant withdrawal symptoms, false negative imaging results, risks which outweigh the value of AdreView imaging, fatal ""Gasping Syndrome"", hypotension, metabolic acidosis, increased incidence of kernicterus, deaths in preterm infants, benzyl alcohol toxicity, decreased cardiac uptake of AdreView, increased long term risk for thyroid neoplasia, transient episode of hypertension"
58,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, cough post-inhalation, respiratory-related deaths, asthma exacerbation, hypersensitivity reactions, paradoxical bronchospasm, tachycardia/heart rate increase/palpitations, pruritus/rash, dizziness"
59,ARCAPTA,boxed warnings,asthma-related death
60,ARCAPTA,warnings and precautions,"clinically significant cardiovascular effects, fatal, Immediate hypersensitivity reactions, Life-threatening paradoxical bronchospasm, asthma-related death, serious asthma-related events, death, deterioration of disease, acute episodes, excessive use of ARCAPTA NEOHALER, fatalities, difficulties in breathing, swallowing, swelling of tongue, lips and face, urticaria, skin rash, paradoxical bronchospasm, increases in pulse rate, systolic or diastolic blood pressure, symptoms, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, aggravate pre-existing diabetes mellitus, ketoacidosis, significant hypokalemia, adverse cardiovascular effects, increases in plasma glucose"
61,INTELENCE,adverse reactions,"Severe skin and hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, Stevens-Johnson syndrome, drug hypersensitivity reaction, erythema multiforme, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, haemorrhagic stroke, rhabdomyolysis, toxic epidermal necrolysis"
62,INTELENCE,warnings and precautions,"Severe skin reactions, potentially life threatening skin reactions, fatal skin reactions, Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 rashes, Grade 4 rashes, rash accompanied by fever, general malaise, fatigue, muscle or joint aches, blisters, oral lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
63,PICATO,adverse reactions,"Ophthalmic Adverse Reaction, Hypersensitivity Reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, Application Site Pain, Application Site Pruritus, Application Site Infection, Periorbital Edema, Headache, Application Site Irritation, Nasopharyngitis, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
64,PICATO,warnings and precautions,"severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, severe reactions, vesiculation/pustulation, erosion/ulceration, hypersensitivity reactions, anaphylaxis, allergic contact dermatitis, erythema, crusting, swelling"
65,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure"
66,VIZAMYL,warnings and precautions,"Hypersensitivity reactions, flushing, dyspnea, image interpretation errors, false positives, radiation risk, increased risk of cancer"
67,POTIGA,adverse reactions,"Retinal abnormalities, potential vision loss, Urinary retention, Skin discoloration, Neuropsychiatric symptoms, Dizziness, somnolence, QT interval effect, Suicidal behavior and ideation, Withdrawal seizures, dizziness, somnolence, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, Nausea, Constipation, Dyspepsia, Fatigue, Asthenia, Influenza, Weight increased, Dizziness, Somnolence, Memory impairment, Tremor, Vertigo, Abnormal coordination, Disturbance in attention, Gait disturbance, Aphasia, Dysarthria, Balance disorder, Paresthesia, Amnesia, Dysphasia, Confusional state, Anxiety, Disorientation, Psychotic disorder, Dysuria, Urinary hesitation, Hematuria, Chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, urinary retention, malaise, increased liver enzymes, weight gain, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy"
68,POTIGA,boxed warnings,"retinal abnormalities, potential vision loss, damage to the photoreceptors, abnormal visual acuity, decreased visual acuity, retinal pigmentary abnormalities, vision changes"
69,POTIGA,warnings and precautions,"urinary retention, skin discoloration, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts or behaviors, retinal abnormalities, potential vision loss, perivascular pigmentation, retinal pigment epithelium clumping, abnormal visual acuity, retinal dystrophy, electroretinogram abnormalities, electrooculogram abnormalities, abnormal fluorescein angiography, diminished sensitivity on visual field testing, urinary hesitation, dysuria, hydronephrosis, renal function impairment, blue skin discoloration, grey-blue skin discoloration, brown skin discoloration, nail bed discoloration, lip discoloration, face discoloration, leg discoloration, palate discoloration, scleral discoloration, conjunctiva discoloration, withdrawal seizures"
70,BREO,adverse reactions,"asthma-related death, asthma-related hospitalization, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness"
71,BREO,boxed warnings,"asthma-related death, increase in asthma-related deaths, increased risk of asthma-related hospitalization in pediatric and adolescent patients"
72,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, overdose, Candida albicans infection of the mouth and pharynx, pneumonia, worsening of infections, tuberculosis, fungal infections, bacterial infections, viral infections, parasitic infections, ocular herpes simplex, chickenpox, measles, impaired adrenal function, hypercorticism, adrenal suppression, paradoxical bronchospasm, cardiovascular disorders, decrease in bone mineral density, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, growth velocity reduction in children and adolescents"
73,DOTAREM,adverse reactions,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, injection site pruritus, injection site warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis"
74,DOTAREM,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal or debilitating fibrosis affecting the skin, muscle and internal organs, Chronic, severe kidney disease, Acute kidney injury"
75,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, Hypersensitivity, Anaphylactoid/anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, fatal or debilitating fibrosis affecting the skin, muscle and internal organs, acute kidney injury, drug-induced kidney toxicity, NSF, circulatory collapse, hypersensitivity reactions, Acute Kidney Injury requiring dialysis, tissue irritation"
76,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
77,NESINA,warnings and precautions,"acute pancreatitis, anaphylaxis, angioedema, severe cutaneous adverse reactions, hepatic failure, hypoglycemia, severe and disabling arthralgia, Stevens-Johnson syndrome, serum alanine aminotransferase (ALT) elevations, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice"
78,EYLEA,adverse reactions,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, intraocular pressure increased, vitreous detachment, Ocular hyperemia, Corneal epithelium defect, Detachment of the retinal pigment epithelium, Injection site pain, Foreign body sensation in eyes, Lacrimation increased, Vision blurred, Intraocular inflammation, Retinal pigment epithelium tear, Injection site hemorrhage, Eyelid edema, Corneal edema, hypersensitivity, retinal detachment, retinal tear, endophthalmitis"
79,EYLEA,warnings and precautions,"endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death"
80,TECFIDERA,adverse reactions,"Anaphylaxis, Angioedema, Progressive multifocal leukoencephalopathy, Lymphopenia, Flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, elevations of hepatic transaminases, eosinophilia"
81,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, difficulty breathing, urticaria, swelling of the throat and tongue, progressive multifocal leukoencephalopathy (PML), death, severe disability, prolonged lymphopenia, lymphocyte counts <0.5x10^9/L, infections, serious infections, flushing, warmth, redness, itching, burning sensation, hospitalization"
82,TREANDA,adverse reactions,"Myelosuppression, Infections, Anaphylaxis and Infusion Reactions, Tumor Lysis Syndrome, Skin Reactions, Other Malignancies, Extravasation injury, pyrexia, nausea, vomiting, fatigue, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, malaise, weakness, dry mouth, somnolence, mucosal inflammation, worsening hypertension, hypertensive crisis, hypersensitivity, Nasopharyngitis, Infection, Herpes simplex, Hyperuricemia, Pruritus, Hemoglobin Decreased, Platelets Decreased, Leukocytes Decreased, Lymphocytes Decreased, Neutrophils Decreased, bilirubin elevations, increased bilirubin, increases in AST, increases in ALT, creatinine levels changes, Tachycardia, Constipation, Stomatitis, Abdominal pain, Dyspepsia, Gastroesophageal reflux disease, Dry mouth, Abdominal pain upper, Abdominal distension, Chills, Edema peripheral, Asthenia, Chest pain, Infusion site pain, Pain, Catheter site pain, Herpes zoster, Upper respiratory tract infection, Urinary tract infection, Sinusitis, Pneumonia, Febrile neutropenia, Oral candidiasis, Weight decreased, Anorexia, Dehydration, Decreased appetite, Hypokalemia, Back pain, Arthralgia, Pain in extremity, Bone pain, Headache, Dizziness, Dysgeusia, Insomnia, Anxiety, Depression, Cough, Dyspnea, Pharyngolaryngeal pain, Wheezing, Nasal congestion, Dry skin, Night sweats, Hyperhidrosis, Hypotension, hyperglycemia, elevated creatinine, hyponatremia, hypocalcemia, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, dysgeusia/taste disorder, atypical pneumonia, sepsis, herpes zoster, erythema, dermatitis, skin necrosis, anaphylaxis, injection or infusion site reactions, phlebitis, pruritus, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, SJS, TEN."
83,TREANDA,warnings and precautions,"myelosuppression, death, infections, fever, signs of infection, Anaphylaxis, Infusion Reactions, Severe and anaphylactic reactions, Tumor Lysis Syndrome, Acute renal failure, Skin Reactions, severe skin reactions, SJS, TEN, Other Malignancies, Pre-malignant and malignant diseases, Extravasation, Embryo-fetal toxicity, severe myelosuppression, neutropenic sepsis, diffuse alveolar hemorrhage, thrombocytopenia, pneumonia, opportunistic infection, CMV, leukocytes, platelets, hemoglobin, neutrophils, dose delays, dose reductions, ANC, platelet count, Infection, pneumonia, sepsis, septic shock, fever, chills, pruritus, rash, anaphylactic and anaphylactoid reactions, allergic-type reactions, antihistamines, antipyretics, corticosteroids, Grade 4 infusion reactions, Grade 3 infusions reactions, blood chemistry, potassium, uric acid levels, Allopurinol, severe skin toxicity, rash, toxic skin reactions, bullous exanthema, toxic epidermal necrolysis, Stevens-Johnson syndrome, myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, TREANDA extravasations, erythema, marked swelling, pain, redness, swelling, pain, infection, necrosis, fetal harm, resorptions, skeletal and visceral malformations, decreased fetal body weights"
84,ELIQUIS,adverse reactions,"Increased risk of thrombotic events after premature discontinuation, Bleeding, Spinal/epidural anesthesia or puncture, bleeding-related adverse reactions, Major bleeding, Intracranial bleed, Hemorrhagic stroke, Gastrointestinal (GI) bleed, Fatal bleeding, Intracranial, Non-intracranial, Hypersensitivity reactions, skin rash, anaphylactic reactions, allergic edema, syncope, adverse reactions, Bleeding, Major (including surgical site), Fatal, Hgb decrease >=2 g/dL, Transfusion of >=2 units RBC, Bleed at critical site, Major+ CRNM, Nausea, Anemia, Contusion, Hemorrhage, Postprocedural hemorrhage, Transaminases increased, Aspartate aminotransferase increased, Gamma-glutamyltransferase increased, thrombocytopenia, hypotension, epistaxis, gastrointestinal hemorrhage, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, operative hemorrhage, Gingival bleeding, hemoptysis, hypersensitivity, muscle hemorrhage, ocular hemorrhage, rectal hemorrhage, gingival bleeding, epistaxis, contusion, hematuria, rectal hemorrhage, hematoma, menorrhagia, hemoptysis, hemorrhagic anemia, hemorrhoidal hemorrhage, gastrointestinal hemorrhage, hematemesis, melena, anal hemorrhage, wound hemorrhage, postprocedural hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma"
85,ELIQUIS,boxed warnings,"thrombotic events, SPINAL/EPIDURAL HEMATOMA, long-term or permanent paralysis"
86,ELIQUIS,warnings and precautions,"serious, potentially fatal bleeding, increased risk of thrombotic events, increased rate of stroke, bleeding, risk of bleeding, signs and symptoms of blood loss, active pathological hemorrhage, epidural or spinal hematoma, long-term or permanent paralysis, neurological impairment, numbness or weakness of the legs, bowel, or bladder dysfunction"
87,BOSULIF,adverse reactions,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval of greater than 500 milliseconds, Platelet Count (Low) less than 50*10^9/L, Absolute Neutrophil Count less than 1*10^9/L, Hemoglobin (Low) less than 80 g/L, SGPT/ALT greater than 5.0*ULN, SGOT/AST greater than 5.0*ULN, Lipase greater than 2*ULN, Phosphorus (Low) less than 0.6 mmol/L, Total Bilirubin greater than 3.0*ULN, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, abnormal hepatic function, liver injury, drug hypersensitivity, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption."
88,BOSULIF,warnings and precautions,"Gastrointestinal Toxicity, diarrhea, nausea, vomiting, abdominal pain, Myelosuppression, Thrombocytopenia, anemia, neutropenia, Hepatic Toxicity, drug induced liver injury, ALT elevation, AST elevation, Fluid Retention, pericardial effusion, pleural effusion, pulmonary edema, peripheral edema, Renal Toxicity, decline in estimated glomerular filtration rate (eGFR), Embryofetal Toxicity, fetal harm"
89,GILENYA,adverse reactions,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, Influenza, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphoma"
90,GILENYA,warnings and precautions,"Bradycardia, atrioventricular conduction, infections, Progressive multifocal leukoencephalopathy (PML), Macular edema, Posterior reversible encephalopathy syndrome (PRES), Decrease in pulmonary function tests (PFT), Liver injury, Blood pressure (BP), symptomatic bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, first-degree AV block, second-degree AV blocks, Mobitz Types I [Wenckebach], 2:1 AV blocks, third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, syncope, bronchitis, herpes zoster, influenza, sinusitis, pneumonia, herpetic infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, Cryptococcal infections, cryptococcal meningitis, Varicella Zoster Virus Antibody Testing/Vaccination, blurred vision, decreased visual acuity, sudden onset of severe headache, altered mental status, visual disturbances, seizure, ischemic stroke, cerebral hemorrhage, forced expiratory volume over 1 second (FEV1), diffusion lung capacity for carbon monoxide (DLCO), dyspnea, elevation of liver transaminases, nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice, dark urine, hypertension, lymphocyte counts decrease."
91,BENLYSTA,adverse reactions,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions, including Anaphylaxis, Infusion Reactions, Depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, mild infusion reactions of nausea, erythematous rash, pruritus, eyelid edema, headache, dyspnea, Fatal anaphylaxis"
92,BENLYSTA,warnings and precautions,"deaths, Serious Infections, fatal infections, Progressive Multifocal Leukoencephalopathy (PML), neurological deficits, fatal cases, Hypersensitivity Reactions, Anaphylaxis, death, Depression, suicidality, worsening depression, suicidal thoughts, mood changes, upper respiratory tract infection, urinary tract infection, nasopharyngitis, sinusitis, bronchitis, influenza, pneumonia, cellulitis, infections leading to discontinuation of treatment, infections resulting in death, malignancies, non-melanoma skin cancers, acute hypersensitivity reactions, rash, nausea, fatigue, myalgia, headache, facial edema, non-acute hypersensitivity reactions, hypotension, angioedema, urticaria, pruritus, dyspnea, Infusion Reactions, bradycardia, skin reactions, psychiatric events, insomnia, anxiety, serious psychiatric events, serious depression, suicides, Live vaccines, Concomitant Use with Other Biologic Therapies or Intravenous Cyclophosphamide"
93,XALKORI,adverse reactions,"Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, abdominal pain, pyrexia, weight increased, pain in extremity, muscle spasm, dizziness, headache, fatigue, neuropathy, rash, renal cyst, ILD, syncope, neutropenia, lymphopenia, hypophosphatemia, ALT elevation, AST elevation, hypokalemia, pneumonia, arrhythmia, acute respiratory distress syndrome, respiratory failure, sepsis, hepatic failure"
94,XALKORI,warnings and precautions,"Fatal hepatotoxicity, Interstitial Lung Disease (ILD)/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Embryofetal Toxicity, Concurrent elevations in alanine aminotransferase (ALT) or aspartate aminotransferase (AST), elevations in ALT, elevations in AST, elevated transaminases, Severe, life-threatening, or fatal interstitial lung disease (ILD)/pneumonitis, QTc prolongation, QTcF greater than or equal to 500 ms, increase from baseline QTcF greater than or equal to 60 ms, Torsade de pointes, polymorphic ventricular tachycardia, serious arrhythmia, Symptomatic bradycardia, heart rate less than 50 beats per minute, Grade 3 syncope, Grade 4 visual field defect with vision loss, Optic atrophy, optic nerve disorder, embryotoxicity, fetotoxicity"
95,CLEVIPREX,adverse reactions,"headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, hypotension, decreased oxygen saturation, reflex tachycardia"
96,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbate heart failure, rebound hypertension"
97,LUMIZYME,adverse reactions,"anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, supraventricular tachycardia, paresthesia, local swelling, diarrhea, pruritus, edema peripheral, rash papular, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions"
98,LUMIZYME,boxed warnings,"anaphylactic reactions, hypersensitivity reactions, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload, acute exacerbation of cardiac compromise, acute exacerbation of respiratory compromise"
99,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, chest discomfort, chest pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension, increased blood pressure, flushing, feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, immune-mediated cutaneous reactions, necrotizing skin lesions, systemic immune-mediated reactions, type III immune-mediated reactions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition, acute cardiorespiratory failure, cardiac hypertrophy, fluid overload, ventricular arrhythmias, bradycardia, cardiac resuscitation, defibrillation, sudden cardiac death, immunogenicity, reduced clinical efficacy, loss of motor function, ventilator dependence, IgG antibody formation, inhibitory antibody activity, IgE antibodies"
100,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash"
101,CERDELGA,warnings and precautions,"prolongation of the PR, QTc, and/or QRS cardiac intervals, cardiac arrhythmias, congestive heart failure, recent acute myocardial infarction, bradycardia, heart block, ventricular arrhythmia, long QT syndrome"
102,NEURACEQ,adverse reactions,"erythema (1.7 %), irritation (1.2 %), pain (3.9 %)"
103,NEURACEQ,warnings and precautions,"Image interpretation errors, false positives, long-term cumulative radiation exposure, increased risk of cancer, unintentional radiation exposure"
104,PROLIA,adverse reactions,"Hypocalcemia, Serious Infections, Dermatologic Adverse Reactions, Osteonecrosis of the Jaw, Atypical Subtrochanteric and Diaphyseal Femoral Fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, constipation, pancreatitis, Anemia, Angina pectoris, Atrial fibrillation, Vertigo, Abdominal pain upper, Flatulence, Gastroesophageal reflux disease, Edema peripheral, Asthenia, Upper respiratory tract infection, Pneumonia, Pharyngitis, Herpes zoster, Bone pain, Myalgia, Spinal osteoarthritis, Sciatica, Insomnia, Rash, Pruritus, Endocarditis, erysipelas, cellulitis, opportunistic infections, epidermal and dermal adverse events, dermatitis, eczema, rashes, New Malignancies, cataracts, Drug-related hypersensitivity reactions, anaphylaxis, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, severe musculoskeletal pain, Marked elevation in serum PTH"
105,PROLIA,warnings and precautions,"hypersensitivity including anaphylactic reactions, Hypocalcemia, Osteonecrosis of the jaw, Atypical femoral fractures, Serious infections including skin infections, Dermatologic reactions: Dermatitis, rashes, and eczema, Severe Bone, Joint, Muscle Pain, Suppression of bone turnover, hypotension, dyspnea, throat tightness, facial and upper airway edema, pruritus, urticaria, marked elevations of serum parathyroid hormone (PTH), severe renal impairment, opportunistic infections, endocarditis, epidermal and dermal adverse events, incapacitating bone, joint, and/or muscle pain, osteonecrosis of the jaw, atypical fractures, delayed fracture healing"
106,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, anemia, iron deficiency anemia, leukopenia, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation"
107,FANAPT,boxed warnings,"increased mortality, death, cardiovascular, heart failure, sudden death, infectious, pneumonia"
108,FANAPT,warnings and precautions,"increased risk of death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, hyperglycemia, diabetes mellitus, polydipsia, polyuria, polyphagia, weakness, Dyslipidemia, Weight Gain, metabolic changes, cardiovascular/cerebrovascular risk, Seizures, Orthostatic hypotension, dizziness, tachycardia, syncope, Leukopenia, Neutropenia, Agranulocytosis, Suicide, Priapism, cognitive and motor impairment, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure, diaphoresis, cardiac dysrhythmia, elevated creatine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, central anticholinergic toxicity, heat stroke, drug fever, primary central nervous system pathology, involuntary dyskinetic movements, hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, body temperature regulation, Dysphagia, aspiration pneumonia, somnolence, sedation."
109,FULYZAQ,adverse reactions,"Upper respiratory tract infection, Bronchitis, Cough, Flatulence, Increased bilirubin, Nausea, Back pain, Arthralgia, Urinary tract infection, Nasopharyngitis, Musculoskeletal pain, Hemorrhoids, Giardiasis, Anxiety, Increased alanine aminotransferase, Abdominal distension, Abdominal pain, Acne, Increased aspartate aminotransferase, Increased conjugated bilirubin, Increased unconjugated blood bilirubin, Constipation, Depression, Dermatitis, Dizziness, Dry mouth, Dyspepsia, Gastroenteritis, Herpes zoster, Nephrolithiasis, Pain in extremity, Pollakiuria, Procedural pain, Seasonal allergy, Sinusitis, Decreased white blood cell count"
110,FULYZAQ,warnings and precautions,"Based on the provided structured product label text, there are no explicit mentions of adverse drug reactions directly associated with the use of FULYZAQ. The text focuses on the risks associated with misdiagnosis or inappropriate treatment of infectious diarrhea, rather than specific adverse reactions to the drug itself. Therefore, there are no adverse drug reactions to extract from this particular excerpt."
111,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, elevation of serum bilirubin laboratory values, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness"
112,EOVIST,boxed warnings,"NEPHROGENIC SYSTEMIC FIBROSIS (NSF), fatal or debilitating fibrosis affecting the skin, muscle and internal organs, Chronic, severe kidney disease, Acute kidney injury"
113,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, anaphylactoid/hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, severe reactions including shock, fatal or debilitating fibrosis affecting the skin, muscle and internal organs, acute kidney injury, drug-induced kidney toxicity, hypersensitivity reactions, anaphylactic reactions, shock, acute kidney injury requiring dialysis, local tissue reactions, myocyte necrosis and inflammation, falsely high or low serum iron values, reduced hepatic contrast, elevated serum ferritin levels, reduced hepatic contrast with high serum bilirubin"
114,ONFI,adverse reactions,"Somnolence or Sedation, Potentiation of Sedation from Concomitant Use with Central Nervous System Depressants, Withdrawal Symptoms, Serious Dermatological Reactions, Physical and Psychological Dependence, Suicidal Behavior and Ideation, constipation, pyrexia, lethargy, drooling, lethargy, somnolence, ataxia, aggression, fatigue, insomnia, Vomiting, Constipation, Dysphagia, Pyrexia, Irritability, Fatigue, Upper respiratory tract infection, Pneumonia, Urinary tract infection, Bronchitis, Decreased appetite, Increased appetite, Somnolence or Sedation, Somnolence, Sedation, Lethargy, Drooling, Ataxia, Psychomotor hyperactivity, Dysarthria, Aggression, Insomnia, Cough, Anemia, eosinophilia, leukopenia, thrombocytopenia, Diplopia, vision blurred, Abdominal distention, Hypothermia, Hepatic enzyme increased, Muscle spasms, Agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, Urinary retention, Aspiration, respiratory depression, Rash, urticaria, angioedema, facial and lip edema"
115,ONFI,warnings and precautions,"Somnolence or Sedation, central nervous system (CNS) depression, Withdrawal Symptoms, Serious Dermatological Reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, Physical and Psychological Dependence, habituation and dependence, Suicidal Behavior and Ideation, suicidal thoughts or behaviors, depression, convulsions, psychosis, hallucinations, behavioral disorder, tremor, anxiety, dysphoria, insomnia, rash, seizure exacerbation, status epilepticus, mood or behavior changes, thoughts about self-harm"
116,COMETRIQ,adverse reactions,"Perforations and Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, fistulas, cardiac arrest, respiratory failure, unspecified death, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone (TSH), Dehydration, Arthralgia, Muscle spasms, Musculoskeletal chest pain, Dysgeusia, Headache, Dizziness, Paresthesia, Peripheral sensory neuropathy, Peripheral neuropathy, Anxiety, Dysphonia, PPES, Hair color changes/depigmentation, graying, Rash, Dry skin, Alopecia, Erythema, Hyperkeratosis, Hypotension, Increased AST, Increased ALT, Increased ALP, Hypocalcemia, Hypophosphatemia, Hyperbilirubinemia, Hypomagnesemia, Hypokalemia, Hyponatremia, Lymphopenia, Neutropenia, Thrombocytopenia, elevated blood pressure, overt hypertension"
117,COMETRIQ,boxed warnings,"Gastrointestinal perforations, fistula formation, Severe hemorrhage, sometimes fatal hemorrhage, hemoptysis, gastrointestinal hemorrhage"
118,COMETRIQ,warnings and precautions,"myocardial infarction, cerebral infarction, serious arterial thromboembolic events, dehiscence, complications requiring medical intervention, hypertensive crisis, osteonecrosis of the jaw, Palmar-plantar Erythrodysesthesia syndrome (PPES), proteinuria, nephrotic syndrome, Reversible posterior leukoencephalopathy syndrome (RPLS), Gastrointestinal (GI) perforations, fistulas, fatal GI fistula, Non-GI fistulas, tracheal/esophageal fistulas, fatal Non-GI fistulas, Serious hemorrhage, fatal hemorrhage, Grade >=3 hemorrhagic events, venous thromboembolism, arterial thromboembolism, acute myocardial infarction, clinically significant arterial thromboembolic complication, treatment-emergent hypertension, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, persistent jaw pain, slow healing of the mouth or jaw after dental surgery, intolerable Grade 2 PPES, Grade 3-4 PPES, seizures, headache, visual disturbances, confusion, altered mental function, embryolethal, skeletal variations, visceral variations, malformations."
119,NULOJIX,adverse reactions,"PTLD, CNS PTLD, other malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-melanoma skin cancer, fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion-related reactions, hypotension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, abdominal pain upper, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, proteinuria, dysuria, renal tubular necrosis, hypotension, dyspnea, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation"
120,NULOJIX,boxed warnings,"post-transplant lymphoproliferative disorder (PTLD), central nervous system (CNS) involvement, increased susceptibility to infection, development of malignancies, graft loss, death"
121,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder (PTLD), new or worsening neurological signs and symptoms, cognitive signs and symptoms, behavioral signs and symptoms, Other malignancies, increased risk of bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, Polyoma virus-associated nephropathy, kidney graft loss, Progressive Multifocal Leukoencephalopathy (PML), JC virus infection, cytomegalovirus (CMV) infection, herpes infection, Pneumocystis jiroveci infection, deteriorating renal function, graft loss, death, acute rejection, Grade III rejection, increased rate of acute rejection, live vaccines."
122,GILOTRIF,adverse reactions,"Diarrhea, Bullous and Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, Serious adverse reactions, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, Dose reductions, Discontinuation of therapy, ventricular dysfunction, Gastrointestinal disorders, Stomatitis, Cheilitis, Skin and subcutaneous tissue disorders, Infections and infestations, Cystitis, Metabolism and nutrition disorders, Respiratory, thoracic and mediastinal disorders, Epistaxis, Rhinorrhea, Investigations, Weight Decreased, General disorders and administration site conditions, Pyrexia, Eye disorders, Conjunctivitis, Alanine aminotransferase increased, Hypokalemia, Aspartate aminotransferase increased, Pancreatitis"
123,GILOTRIF,warnings and precautions,"Diarrhea, dehydration, renal failure, severe and prolonged diarrhea, Bullous and Exfoliative Skin Disorders, severe bullous, blistering, exfoliating lesions, life-threatening cutaneous reactions, Interstitial lung disease (ILD), acute onset or worsening of pulmonary symptoms, Hepatic toxicity, Fatal hepatic impairment, liver testing, worsening liver tests, Keratitis, ulcerative keratitis, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, Embryofetal toxicity, fetal harm, embryotoxic, abortions, maternal toxicity."
124,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
125,DATSCAN,warnings and precautions,"Hypersensitivity reactions, skin erythema, pruritis, anaphylactic, thyroid neoplasia"
126,KALBITOR,adverse reactions,"Hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, local pruritus, erythema, pain, irritation, urticaria, bruising, anti-ecallantide antibodies, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies"
127,KALBITOR,boxed warnings,"Anaphylaxis, hypersensitivity reactions"
128,KALBITOR,warnings and precautions,"anaphylaxis, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
129,APTIOM,adverse reactions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions and Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, asthenia, gait disturbance, peripheral edema, urinary tract infections, fall, balance disorder, dysarthria, memory impairment, nystagmus, depression, insomnia, cough, rash, hypertension, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase."
130,APTIOM,warnings and precautions,"Suicidal thoughts or behavior, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Anaphylactic Reactions, Angioedema, Hyponatremia, dizziness, disturbance in gait and coordination, somnolence, fatigue, cognitive dysfunction, visual changes, increased seizure frequency, status epilepticus, Drug Induced Liver Injury, abnormal thyroid function tests"
131,DUAVEE,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, all-cause mortality, serious adverse reactions, hot flush, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis"
132,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, increased risk of endometrial cancer, endometrial hyperplasia, stroke, deep vein thrombosis (DVT), increased risk of stroke, increased risk of deep vein thrombosis, increased risk of probable dementia, cancer of the uterus, unusual vaginal bleeding, cancer of the womb, strokes, blood clots, dementia, decline in brain function, hot flushes, osteoporosis, thin weak bones, blood clots, allergic reactions, unusual vaginal bleeding, certain cancers, cancer of the breast, liver problems, bleeding disorder, pregnant, breastfeeding, unusual vaginal bleeding, asthma, epilepsy, seizures, diabetes, migraine, endometriosis, lupus, heart problems, thyroid problems, kidney problems, high calcium levels in your blood, surgery, bed rest, nauseavomitingbreast tendernessdizzinessabdominal painfeeling tiredvaginal bleeding, blood clots, stroke, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, dementia, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems, asthma, diabetes, epilepsy, migraines, porphyria, lupus, liver problems, new breast lumps, changes in vision or speech, sudden new severe headaches, severe pains in your chest or legs with or without shortness of breath, weakness and fatigue, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain"
133,DUAVEE,warnings and precautions,"cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, probable dementia, visual abnormalities, elevated blood pressure, hypertriglyceridemia, hepatic impairment, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, exacerbation of diabetes mellitus, exacerbation of epilepsy, exacerbation of migraine, exacerbation of porphyria, exacerbation of systemic lupus erythematosus, hepatic hemangiomas, impaired glucose tolerance"
134,KALYDECO,adverse reactions,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, aspartate aminotransferase increased, blood glucose increased, hepatic enzyme increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne"
135,KALYDECO,warnings and precautions,"Elevated transaminases (ALT or AST), increased transaminase levels, non-congenital lens opacities/cataracts"
136,AMYVID,adverse reactions,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
137,AMYVID,warnings and precautions,"Image interpretation errors, false negatives, Radiation risk, increased risk of cancer, unintentional radiation exposure"
138,TIVICAY,adverse reactions,"Hypersensitivity reactions, Effects on serum liver biochemistries in patients with hepatitis B or C co-infection, Fat Redistribution, Immune Reconstitution Syndrome, insomnia, fatigue, headache, Treatment-emergent Adverse Drug Reactions, depression, abnormal dreams, Dizziness, Nausea, Diarrhea, Rash, Vertigo, Abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, Hepatitis, Myositis, Suicidal ideation, attempt, behavior, or completion, Renal impairment, Pruritus, ALT abnormalities, AST abnormalities, Creatine kinase abnormalities, Hyperglycemia, Lipase abnormalities, Total neutrophils abnormalities, elevated ALT, elevated AST, elevated cholesterol, elevated creatinine kinase, hyperglycemia, elevated lipase, neutropenia, increased serum creatinine, rash, abdominal pain"
139,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, transaminase elevations, hepatotoxicity, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
140,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, Pain, Pruritus, Erythema, Pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation"
141,ULESFIA,warnings and precautions,"gasping syndrome, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, allergic dermatitis, irritant dermatitis"
142,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
143,TRULICITY,adverse reactions,"Risk of Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, documented symptomatic hypoglycemia, severe hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, immunogenicity, systemic hypersensitivity, severe urticaria, systemic rash, facial edema, lip swelling, injection-site reactions, injection-site rash, erythema, PR Interval Prolongation, first degree Atrioventricular (AV) Block, Amylase and Lipase Increase"
144,TRULICITY,boxed warnings,"thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
145,TRULICITY,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Severe Gastrointestinal Disease"
146,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, hypersensitivity, Serious Adverse Reactions, Adverse Reactions Leading to Discontinuation, Diarrhea, Nausea, Constipation, Vomiting, Increased transaminases, Hypokalemia, Rash, Phlebitis, Anemia, Eosinophilia, Neutropenia, Thrombocytopenia, Bradycardia, Palpitations, Abdominal pain, Pyrexia, Hepatitis, Anaphylaxis, Clostridium difficile colitis, Hyperglycemia, Hyperkalemia, Dizziness, Convulsion, Renal failure, Urticaria, Agranulocytosis"
147,TEFLARO,warnings and precautions,"Serious hypersensitivity (anaphylactic) reactions, Clostridium difficile-associated diarrhea (CDAD), Direct Coombs' test seroconversion, mild diarrhea, fatal colitis, increased morbidity, mortality, refractory to antimicrobial therapy, colectomy, drug-induced hemolytic anemia, development of drug-resistant bacteria"
148,JARDIANCE,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), urinary tract infections, female genital mycotic infections, Upper respiratory tract infection, Increased urination, Dyslipidemia, Arthralgia, Male genital mycotic infections, Nausea, Thirst (including polydipsia), blood pressure (ambulatory) decreased, blood pressure systolic decreased, dehydration, hypovolemia, orthostatic hypotension, syncope, polyuria, pollakiuria, nocturia, serum creatinine increases, eGFR decreases, vaginal mycotic infection, vaginal infection, genital infection fungal, vulvovaginal candidiasis, vulvitis, Phimosis, asymptomatic bacteriuria, cystitis, LDL-C increases, Hematocrit increases"
149,JARDIANCE,warnings and precautions,"Hypotension, Impairment in renal function, Hypoglycemia, Genital mycotic infections, Urinary tract infections, Increased LDL-C"
150,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, hepatic failure (some fatal), jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions"
151,ULORIC,warnings and precautions,"gout flares, cardiovascular thromboembolic events, cardiovascular deaths, non-fatal myocardial infarctions, non-fatal strokes, hepatic failure, fatal hepatic failure, non-fatal hepatic failure, transaminase elevations, AST elevations, ALT elevations, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, abnormal liver tests, drug-induced liver injury"
152,KYPROLIS,adverse reactions,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, myocardial infarction, upper respiratory tract infection, constipation, peripheral neuropathies NEC, insomnia, nasopharyngitis, bronchitis, hypocalcemia, hyperglycemia, rash, embolic and thrombotic events, venous, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, headache, dizziness, insomnia, dyspnea, epistaxis, renal failure, hypertension, dehydration, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), tumor lysis syndrome, posterior reversible encephalopathy syndrome (PRES)."
153,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction with fatal outcome, myocardial ischemia, Acute Renal Failure, Tumor Lysis Syndrome (TLS), Acute Respiratory Distress Syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, Pulmonary Hypertension, Dyspnea, Hypertension including hypertensive crisis, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), Posterior reversible encephalopathy syndrome (PRES), Embryo-fetal Toxicity, congestive heart failure, pulmonary edema, decreased ejection fraction, restrictive cardiomyopathy, cardiac arrest, renal impairment, renal failure, pneumonitis, interstitial lung disease, Pulmonary arterial hypertension (PAH), deep venous thrombosis, pulmonary embolism, fever, chills, arthralgia, myalgia, facial flushing, facial edema, vomiting, weakness, shortness of breath, hypotension, syncope, chest tightness, angina, increased serum transaminases, seizure, headache, lethargy, confusion, blindness, altered consciousness, visual disturbances, neurological disturbances"
154,YERVOY,adverse reactions,"Immune-mediated enterocolitis, Immune-mediated hepatitis, Immune-mediated dermatitis, Immune-mediated neuropathies, Immune-mediated endocrinopathies, Other immune-mediated adverse reactions, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, Enterocolitis, Hepatotoxicity, Dermatitis, Neuropathy, Endocrinopathy, Hypopituitarism, Adrenal insufficiency, Pneumonitis, Meningitis, Nephritis, Eosinophilia, Pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)"
155,YERVOY,boxed warnings,"severe and fatal immune-mediated adverse reactions, enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy"
156,YERVOY,warnings and precautions,"severe and fatal immune-mediated reactions, severe immune-mediated enterocolitis, life-threatening immune-mediated enterocolitis, fatal immune-mediated enterocolitis, diarrhea, fever, ileus, peritoneal signs, moderate immune-mediated enterocolitis, abdominal pain, mucus or blood in stool, intestinal perforation, complications from enterocolitis, severe enterocolitis, moderate enterocolitis, high-dose corticosteroids, Infliximab, severe hepatotoxicity, life-threatening hepatotoxicity, fatal hepatotoxicity, moderate hepatotoxicity, liver function test abnormalities, immune-mediated hepatitis, hepatotoxicity, increases in transaminases, severe immune-mediated dermatitis, life-threatening immune-mediated dermatitis, fatal immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash complicated by full thickness dermal ulceration, necrotic manifestations, bullous manifestations, hemorrhagic manifestations, moderate dermatitis, pruritus, severe neuropathy, fatal Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, Guillain-Barre syndrome, motor or sensory neuropathy, weakness, sensory alterations, paresthesia, severe immune-mediated endocrinopathies, life-threatening immune-mediated endocrinopathies, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, moderate endocrinopathy, hyperthyroidism, Cushing's syndrome, hormone replacement therapy, adrenal hormones, thyroid hormones, hypophysitis, adrenal crisis, hyperthyroidism, hypothyroidism, fatigue, headache, mental status changes, abdominal pain, unusual bowel habits, hypotension, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, immune-mediated ocular disease, corticosteroid eye drops."
157,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor"
158,GADAVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal or debilitating fibrosis affecting the skin, muscle and internal organs, Chronic, severe kidney disease, Acute kidney injury"
159,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, Anaphylactic reactions, hypersensitivity reactions with cardiovascular manifestations, hypersensitivity reactions with respiratory manifestations, hypersensitivity reactions with cutaneous manifestations, death from hypersensitivity reactions, fatal or debilitating fibrosis affecting the skin, fatal or debilitating fibrosis affecting the muscle, fatal or debilitating fibrosis affecting internal organs, acute kidney injury, drug-induced kidney toxicity, moderate irritation from extravasation, Overestimation of Extent of Malignant Disease in MRI of the Breast"
160,OTEZLA,adverse reactions,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, tension headache, fatigue, insomnia, back pain, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound)"
161,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, weight loss, loss of efficacy, reduction of systemic exposure of apremilast, suicidal ideation and behavior, suicidal behavior, attempted suicide, committed suicide"
162,DYSPORT,adverse reactions,"Distant Spread of Toxin Effect, muscular weakness, dysphagia, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, breathing difficulties, dyspnea, muscle atrophy, blood glucose increase, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site reaction, eyelid ptosis, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, cough, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, erythema, excessive granulation tissue, gait disturbance, hypertonia, sensation of heaviness."
163,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
164,DYSPORT,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, exacerbate clinical effects of treatment, transmission of Creutzfeldt-Jakob disease (CJD), asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death related to spread of toxin effects, severe dysphagia, use of a feeding tube, aspiration, weaken neck muscles, critical loss of breathing capacity, respiratory failure, surgical alterations to the facial anatomy, excessive weakness, atrophy in the target muscle(s), marked facial asymmetry, inflammation at the injection site(s), excessive dermatochalasis, deep dermal scarring, thick sebaceous skin, inability to lessen glabellar lines, increased incidence of eyelid ptosis, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junction disorders, severe dysphagia, respiratory compromise, transmission of viral diseases, immune reaction when injected intradermally"
165,FIRAZYR,adverse reactions,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
166,FIRAZYR,warnings and precautions,Laryngeal attacks
167,INVOKANA,adverse reactions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), female genital mycotic infections, urinary tract infection, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy (i.e., asthenia), pancreatitis (acute or chronic), hypersensitivity-related adverse reactions (including erythema, rash, pruritus, urticaria, and angioedema), photosensitivity-related adverse reactions (including photosensitivity reaction, polymorphic light eruption, and sunburn), Volume Depletion-Related Adverse Reactions (e.g., hypotension, postural dizziness, orthostatic hypotension, syncope, and dehydration), falls, significant renal function decline, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, vulvovaginal mycotic infection, vulvovaginal candidiasis, vulvovaginitis, candidal balanitis, balanoposthitis, phimosis, hypoglycemia, severe hypoglycemia, bone fractures, increases in serum potassium, severe elevations of serum potassium, increases in serum magnesium, increases in serum phosphate, increases in Low-Density Lipoprotein Cholesterol (LDL-C) and non-High-Density Lipoprotein Cholesterol (non-HDL-C), increases in hemoglobin, decreases in Bone Mineral Density (BMD)."
168,INVOKANA,warnings and precautions,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C"
169,XTANDI,adverse reactions,"Seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections or sepsis, falls and fall-related injuries, hypertensive crisis."
170,XTANDI,warnings and precautions,"Seizure occurred in 0.9% of patients, Seizure occurred in 0.1% of patients, Permanently discontinue XTANDI in patients who develop a seizure, 7 of 800 (0.9%) patients treated with XTANDI experienced a seizure, no patients treated with placebo experienced a seizure, Seizure occurred from 31 to 603 days after initiation of XTANDI, 1 of 871 (0.1%) chemotherapy-naive patients treated with XTANDI experienced a seizure, 1 of 844 (0.1%) patients treated with placebo experienced a seizure, Patients experiencing seizure were permanently discontinued from therapy, all seizure events resolved, There is no clinical trial experience re-administering XTANDI to patients who experienced seizure, Limited safety data are available in patients with predisposing factors for seizure, history of seizure, underlying brain injury with loss of consciousness, transient ischemic attack within the past 12 months, cerebral vascular accident, brain metastases, brain arteriovenous malformation, risk of seizure associated with XTANDI use, Permanently discontinue XTANDI in patients who develop a seizure during treatment."
171,AFINITOR,adverse reactions,"Non-infectious pneumonitis, Infections, Angioedema with concomitant use of ACE inhibitors, Oral ulceration, Renal failure, Impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hypercholesterolemia, hyperglycemia, increased aspartate transaminase (AST), anemia, leukopenia, thrombocytopenia, lymphopenia, increased alanine transaminase (ALT), hypertriglyceridemia, lymphopenia, hyperglycemia, anemia, decreased potassium, increased AST, increased ALT, thrombocytopenia, hyperglycemia, dyspnea, pneumonitis, diarrhea, hypercholesterolemia, hypertriglyceridemia, hyperglycemia, lymphopenia, increased creatinine, acute renal failure, acute respiratory distress, cardiac arrest, death (cause unknown), hepatic failure, pneumonia, sepsis, pulmonary embolism, hypoglycemia, myocardial infarction with congestive heart failure, sudden death, renal failure, thrombosis, pulmonary embolus, stomatitis, rash, diarrhea, fatigue, edema, abdominal pain, nausea, fever, headache, decreased hemoglobin, hyperglycemia, alkaline phosphatase increased, hypercholesterolemia, bicarbonate decreased, increased aspartate transaminase (AST), lymphopenia, decreased hemoglobin, hypophosphatemia, increased alkaline phosphatase, neutropenia, potassium decreased, thrombocytopenia, stomatitis, infections, asthenia, fatigue, cough, diarrhea, anemia, hypercholesterolemia, hypertriglyceridemia, hyperglycemia, lymphopenia, increased creatinine, acute respiratory failure, infection, acute renal failure, stomatitis, diarrhea, nausea, vomiting, infections, asthenia, fatigue, edema peripheral, pyrexia, mucosal inflammation, cough, dyspnea, epistaxis, pneumonitis, rash, pruritus, dry skin, anorexia, headache, dysgeusia, pain in extremity, abdominal pain, dry mouth, hemorrhoids, dysphagia, impaired wound healing, pleural effusion, pharyngolaryngeal pain, rhinorrhea, hand-foot syndrome, nail disorder, erythema, onychoclasis, skin lesion, acneiform dermatitis, angioedema, exacerbation of pre-existing diabetes mellitus, new onset of diabetes mellitus, insomnia, dizziness, paresthesia, eyelid edema, conjunctivitis, hypertension, deep vein thrombosis, renal failure, tachycardia, congestive cardiac failure, jaw pain, hemorrhage, hemoglobin decreased, lymphocytes decreased, platelets decreased, neutrophils decreased, cholesterol increased, triglycerides increased, glucose increased, creatinine increased, phosphate decreased, aspartate transaminase (AST) increased, alanine transaminase (ALT) increased, bilirubin increased, stomatitis, vomiting, diarrhea, peripheral edema, upper respiratory tract infection, arthralgia, cough, acne, amenorrhea, menorrhagia, menstrual irregularities, vaginal hemorrhage, epistaxis, decreased appetite, otitis media, depression, abnormal taste, increased blood luteinizing hormone (LH) levels, increased blood follicle stimulating hormone (FSH) levels, hypersensitivity, ovarian cyst, pneumonitis, angioedema, anemia, leucopenia, neutropenia, lymphopenia, thrombocytopenia, hypercholesterolemia, hypertriglyceridemia, hypophosphatemia, alkaline phosphatase increased, elevated aspartate transaminase (AST), elevated alanine transaminase (ALT), fasting hyperglycemia, stomatitis, respiratory tract infection, pyrexia, pneumonia, gastroenteritis, aggression, agitation, rash, elevated partial thromboplastin time, neutropenia, elevated aspartate transaminase (AST), hypertriglyceridemia, elevated alanine transaminase (ALT), hypophosphatemia, cellulitis, hyperglycemia, elevated creatinine, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy."
172,AFINITOR,warnings and precautions,"non-infectious pneumonitis, fatal cases, infections, fatal, Angioedema, Oral ulceration, Mouth ulcers, stomatitis, oral mucositis, Renal failure, acute renal failure, fatal outcome, Impaired wound healing, wound-related complications, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, Laboratory test alterations, Elevations of serum creatinine, urinary protein, blood glucose, lipids, Decreases in hemoglobin, neutrophils, platelets, Vaccinations, Embryo-fetal toxicity, Fetal harm, pneumonia, mycobacterial infections, bacterial infections, invasive fungal infections, aspergillosis, candidiasis, pneumocystis jiroveci pneumonia (PJP), viral infections, hepatitis B virus, sepsis, respiratory failure, hepatic failure, hypoxia, pleural effusion, cough, dyspnea, opportunistic infections, pneumocystis jiroveci pneumonia (PJP), swelling of the airways or tongue, respiratory impairment, Hyperglycemia, hyperlipidemia, hypertriglyceridemia, Decreased hemoglobin, lymphocytes, neutrophils, platelets, Hepatic Impairment, Exposure to everolimus increased"
173,ENTEREG,adverse reactions,"dyspepsia (ENTEREG, 1.5%; placebo, 0.8%)"
174,ENTEREG,boxed warnings,myocardial infarction
175,ENTEREG,warnings and precautions,"myocardial infarctions, abdominal pain, nausea and vomiting, diarrhea, serious adverse reactions in patients with severe hepatic impairment, serious adverse reactions in patients with complete gastrointestinal obstruction, serious adverse reactions in pancreatic and gastric anastomoses"
176,COARTEM,adverse reactions,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, hypersensitivity reactions, pyrexia, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, cough, pruritus, rash, vertigo, malaria, nasopharyngitis, chills, asthenia, fatigue, abdominal pain, diarrhea, nausea, Plasmodium falciparum infection, rhinitis, anorexia, headache, dizziness, splenomegaly, anemia, hepatomegaly, aspartate aminotransferase increased, arthralgia, myalgia, rash, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, malaria, nasopharyngitis, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption)"
177,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, congenital prolongation of the QT interval, sudden death, decreased exposure to lumefantrine, decreased efficacy, decreased concentrations of artemether and/or lumefantrine, loss of antimalarial efficacy, potentiate QT prolongation, increased concentrations of artemether and/or lumefantrine, reduced effectiveness of hormonal contraceptives, increased plasma concentrations of coadministered drug, increased risk of adverse effects, risk of recrudescence"
178,DALVANCE,adverse reactions,"nausea (5.5%), headache (4.7%), diarrhea (4.4%), vomiting (2.8%), rash (2.7%), pruritus (2.1%), anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma"
179,DALVANCE,warnings and precautions,"Serious hypersensitivity (anaphylactic) and skin reactions, Rapid intravenous infusion of glycopeptide antibacterial agents can cause reactions, ALT elevations, Clostridium difficile-associated diarrhea (CDAD), flushing of the upper body, urticaria, pruritus, rash, post-baseline alanine aminotransferase (ALT) elevation greater than 3 times the upper limit of normal (ULN), abnormalities in liver tests (ALT, AST, bilirubin), mild diarrhea to fatal colitis, increased morbidity and mortality, refractory to antibacterial therapy, may require colectomy"
180,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
181,FERRIPROX,boxed warnings,"agranulocytosis, serious infections, death, neutropenia, infection"
182,FERRIPROX,warnings and precautions,"infection, fetal harm, agranulocytosis, neutropenia, death, increased ALT values, increased AST values, decreased plasma zinc concentrations"
183,PRADAXA,adverse reactions,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, diarrhea, dyspepsia, nausea, upper abdominal pain, hemorrhagic stroke, intracranial hemorrhage, subarachnoid bleed, subdural bleed, gastrointestinal bleeds, fatal bleeding, non-intracranial fatal bleed, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, symptomatic bleeding in a critical area or organ, intraocular bleeding, intraspinal bleeding, intramuscular bleeding with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, clinically relevant non-major bleeding, myocardial infarction, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, angioedema, thrombocytopenia, esophageal ulcer"
184,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, long-term or permanent paralysis, neurological impairment"
185,PRADAXA,warnings and precautions,"serious and fatal bleeding, thrombotic events, blood loss, hypotension, active pathological bleeding, bleeding, thrombocytopenia, epidural or spinal hematoma, long-term or permanent paralysis, neurological impairment, midline back pain, sensory and motor deficits, bowel and/or bladder dysfunction, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions requiring intervention for hemodynamic compromise"
186,VORAXAZE,adverse reactions,"Serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction and failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor"
187,VORAXAZE,warnings and precautions,"Serious allergic reactions, anaphylactic reactions, Serious allergic reactions occurred in less than 1% of patients"
188,HORIZANT,adverse reactions,"Somnolence/sedation, dizziness, RLS, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, asthenia, insomnia, confusional state, breast enlargement, gynecomastia, elevated creatine kinase"
189,HORIZANT,warnings and precautions,"Driving impairment, Somnolence/sedation, Dizziness, Suicidal thoughts or behaviors, Fatigue/asthenia, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Withdrawal seizure, Pancreatic acinar cell adenoma, Pancreatic acinar cell carcinoma, Tumors (breast, brain, lung, adrenal, non-Hodgkin's lymphoma, endometrial carcinoma in situ), Tumor worsening (brain, breast, prostate)"
190,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, gastroenteritis viral, change in color vision, Non-arteritic anterior ischemic optic neuropathy (NAION)"
191,STENDRA,warnings and precautions,"hypotension, erection lasts greater than 4 hours, sudden loss of vision, sudden decrease or loss of hearing, myocardial infarction, stroke, life-threatening arrhythmia, coronary revascularization, resting hypotension, hypertension, unstable angina, angina with sexual intercourse, congestive heart failure, transient decreases in sitting blood pressure, prolonged erection, priapism, penile tissue damage, permanent loss of potency, anatomical deformation of the penis, sickle cell anemia, multiple myeloma, leukemia, non-arteritic anterior ischemic optic neuropathy (NAION), sudden decrease or loss of hearing, tinnitus, dizziness, symptomatic hypotension, lightheadedness, fainting, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, headache, bleeding disorders, active peptic ulceration, anti-aggregatory effect"
192,ADCETRIS,adverse reactions,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Severe Renal Impairment, Moderate Hepatic Impairment, Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, anaphylaxis, infusion-related reactions, non-infectious pulmonary toxicity, serious adverse reactions, pneumonia, hepatotoxicity, peripheral sensory neuropathy, dose modifications, treatment discontinuation, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, Toxic epidermal necrolysis, immunogenicity, infusion reactions, neutralizing antibodies."
193,ADCETRIS,boxed warnings,"PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML), JC virus infection, death"
194,ADCETRIS,warnings and precautions,"peripheral neuropathy, neuropathy, hypoesthesia, hyperesthesia, paresthesia, discomfort, burning sensation, neuropathic pain, weakness, anaphylaxis, infusion reactions, Hematologic toxicities, fever, Grade 3 neutropenia, Grade 4 neutropenia, dose delays, dose reductions, discontinuation, G-CSF prophylaxis, Serious infections, opportunistic infections, bacterial infections, fungal infections, viral infections, pneumonia, bacteremia, sepsis, septic shock, fatal outcomes, Tumor lysis syndrome, Hepatotoxicity, hepatocellular injury, elevations of transaminases, elevations of bilirubin, Progressive Multifocal Leukoencephalopathy (PML), JC virus infection, central nervous system abnormalities, Pulmonary Toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), cough, dyspnea, Serious dermatologic reactions, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), Embryo-fetal toxicity, fetal harm, decreased embryo viability, fetal malformations."
195,ZERBAXA,adverse reactions,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, renal failure acute, increased mortality, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, renal impairment, renal failure, dyspnea, urticaria, venous thrombosis"
196,ZERBAXA,warnings and precautions,"Decreased efficacy in patients with baseline CrCl of 30 to <=50 mL/min, Serious hypersensitivity (anaphylactic) reactions, Clostridium difficile-associated diarrhea (CDAD), fatal colitis"
197,ZYDELIG,adverse reactions,"Hepatotoxicity, Severe Diarrhea or Colitis, Pneumonitis, Intestinal Perforation, Severe Cutaneous Reactions, Anaphylaxis, Neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, pneumonia, sepsis, febrile neutropenia, elevated transaminases, nausea, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, neutrophil count decreased, lymphocyte count decreased, lymphocyte count increased, GGT increased, triglycerides increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased"
198,ZYDELIG,boxed warnings,"FATAL AND SERIOUS TOXICITIES: HEPATIC, SEVERE DIARRHEA, COLITIS, PNEUMONITIS, INTESTINAL PERFORATION, Fatal and/or serious hepatotoxicity, Fatal and/or serious and severe diarrhea, Fatal and serious pneumonitis, Fatal and serious intestinal perforation"
199,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, fatal and/or serious hepatotoxicity, elevations in ALT or AST greater than 5 times the upper limit of normal, recurrence of ALT and AST elevations, severe diarrhea or colitis, fatal and serious pneumonitis, cough, dyspnea, hypoxia, interstitial infiltrates, decline by more than 5% in oxygen saturation, fatal and serious intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, serious allergic reactions, treatment-emergent Grade 3 or 4 neutropenia, teratogenic in rats"
200,SIMPONI,adverse reactions,"Serious Infections, Malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, ALT elevations >= 5 * ULN, ALT elevations >= 3 * ULN, formation of autoantibodies, lupus-like syndrome, newly ANA-positive, newly positive anti-dsDNA antibodies, infusion reaction, antibodies to SIMPONI ARIA, neutralizing antibodies, Upper respiratory tract infection (such as upper respiratory tract infection, nasopharyngitis, pharyngitis, laryngitis, and rhinitis), Viral infections (such as influenza and herpes), Bacterial infections, Bronchitis, Hypertension, Rash, Pyrexia, Leukopenia, Superficial fungal infection, sinusitis, lower respiratory tract infection (pneumonia), pyelonephritis, Alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, Dizziness, paresthesia, Constipation, Melanoma, Serious systemic hypersensitivity reactions (including anaphylactic reaction), sarcoidosis, Interstitial lung disease, Skin exfoliation, bullous skin reactions"
201,SIMPONI,boxed warnings,"serious infections leading to hospitalization or death, tuberculosis (TB), bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, serious infection, sepsis, latent TB, active TB, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, disseminated disease, severe systemic illness, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria, signs and symptoms of infection, tuberculosis in patients who tested negative for latent tuberculosis, lymphoma, malignancies, some fatal"
202,SIMPONI,warnings and precautions,"serious infections, invasive fungal infections, Hepatitis B reactivation, Malignancies, Heart failure, Demyelinating disease, Hypersensitivity reactions, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis, sepsis, reactivation of tuberculosis, new tuberculosis infections, Hepatitis B Virus Reactivation, Malignancies in Pediatric Patients, lymphoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, Malignancies in Adult Patients, lymphoma, acute and chronic leukemia, hepatosplenic T-cell lymphoma (HSTCL), Melanoma, Merkel cell carcinoma, Congestive Heart Failure, worsening congestive heart failure, new onset CHF, Demyelinating Disorders, central nervous system demyelinating disorders, multiple sclerosis (MS), peripheral demyelinating disorders, Guillain-Barre syndrome, central demyelination, optic neuritis, peripheral demyelinating polyneuropathy, Hematologic Cytopenias, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia, Vaccinations/Therapeutic Infectious Agents, clinical infections, disseminated infections, Hypersensitivity Reactions, anaphylactic reaction, serious allergic reaction"
203,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, febrile neutropenia, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, infection, overdose, confusion, Staphylococcal bacteremia, Anemia, Neutropenia, Thrombocytopenia, Leukopenia, Diarrhea, Abdominal pain, Vomiting, Fatigue, Chills, Chest pain, Cytokine release syndrome, Other pathogen infections, Bacterial infections, Fungal infections, Viral infections, Pneumonia, Sepsis, Increased alanine aminotransferase, Increased aspartate aminotransferase, Increased weight, Hypomagnesemia, Hyperglycemia, Decreased appetite, Hypophosphatemia, Back pain, Pain in extremity, Bone pain, Arthralgia, Dizziness, Insomnia, Cough, Dyspnea, Hypotension, Hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, encephalopathy, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm"
204,BLINCYTO,boxed warnings,"Cytokine Release Syndrome (CRS), life-threatening, fatal, Neurological toxicities, severe, life-threatening, fatal"
205,BLINCYTO,warnings and precautions,"Infections, Effects on Ability to Drive and Use Machines, Preparation and Administration Errors, Cytokine Release Syndrome (CRS), life-threatening or fatal CRS, Infusion reactions, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), Neurological Toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, Tumor Lysis Syndrome (TLS), Neutropenia, Febrile Neutropenia, Elevated Liver Enzymes, transient elevations in liver enzymes, Grade 3 or greater elevations in liver enzymes, Leukoencephalopathy, Preparation and Administration Errors, underdose, overdose"
206,NATAZIA,adverse reactions,"Serious cardiovascular events and stroke, Vascular events, Liver disease, Irregular uterine bleeding, Nausea, Breast tenderness, Headache, headaches, irregular uterine bleeding, headache (including migraines), breast tenderness, pain, menstrual disorders, nausea/ or vomiting, acne, mood changes, increased weight, menstrual disorder (metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding), mood changes (depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying), headache (including migraines), weight increased, headache (including migraines), breast pain, discomfort or tenderness, menstrual disorders (metrorrhagia, menstruation irregular, menorrhagia, vaginal hemorrhage, dysfunctional uterine bleeding, genital hemorrhage, abnormal withdrawal bleeding, uterine hemorrhage), nausea or vomiting, acne, mood changes (depression, mood swings, depressed mood, mood altered, affect lability, dysthymic disorder, crying), increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, Venous and arterial thromboembolic events (including pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction and stroke), hypertension, Gallbladder disease, hepatitis, Hypersensitivity, Fluid retention, hypertriglyceridemia, Dizziness, Chloasma, angioedema, erythema nodosum, erythema multiforme, Gastrointestinal symptoms (for example, abdominal pain), Vulvovaginal candidiasis"
207,NATAZIA,boxed warnings,"CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS, risk of serious cardiovascular events from combination oral contraceptives (COC) use, increases with age, particularly in women over 35 years of age, increases with the number of cigarettes smoked"
208,NATAZIA,warnings and precautions,"thrombotic event, jaundice, uncontrolled hypertension, hypertension with vascular disease, significant change in headaches, irregular bleeding, amenorrhea, decreased contraceptive efficacy, venous thromboembolism, arterial thromboses, strokes, myocardial infarctions, thromboembolic disease, retinal vein thrombosis, carcinoma of the breasts, cervical cancer, intraepithelial neoplasia, hepatic adenomas, intra-abdominal hemorrhage, hepatocellular carcinoma, cholestasis, increased blood pressure, gallbladder disease, decreased glucose tolerance, adverse lipid changes, pancreatitis, new headaches, recurrent headaches, persistent headaches, severe headaches, cerebrovascular event, breakthrough bleeding, spotting, intracyclic bleeding, depression, changes in laboratory tests, hereditary angioedema, chloasma"
209,DIFICID,adverse reactions,"nausea (11%), vomiting (7%), abdominal pain (6%), gastrointestinal hemorrhage (4%), anemia (2%), neutropenia (2%), vomiting (0.5%), anemia (2%), neutropenia (2%), nausea (11%), vomiting (7%), abdominal pain (6%), gastrointestinal hemorrhage (4%), abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions (dyspnea, angioedema, rash, pruritus)"
210,DIFICID,warnings and precautions,"acute hypersensitivity reactions, angioedema, dyspnea, pruritus, rash, severe hypersensitivity reaction, hypersensitivity reactions, allergy to other macrolides, development of drug-resistant bacteria"
211,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, high markedly abnormal platelet counts, high markedly abnormal WBC counts, rash, pruritus, angioedema"
212,EDARBI,boxed warnings,"FETAL TOXICITY, injury and death to the developing fetus"
213,EDARBI,warnings and precautions,"fetal renal function reduction, fetal and neonatal morbidity, fetal and neonatal death, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure, increases in serum creatinine, increases in blood urea nitrogen"
214,IMBRUVICA,adverse reactions,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, renal failure, increases in creatinine, stomatitis, dyspepsia, sinusitis, pyrexia, asthenia, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, hyperuricemia, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, elevated uric acid levels, hyperuricemia, pyrexia, peripheral neuropathy, second malignancies, laceration, anxiety, insomnia, hypertension, contusion, vision blurred, pruritus, arthropathy, skin cancer, hypersensitivity reactions, anaphylactic shock (fatal), urticaria, angioedema"
215,IMBRUVICA,warnings and precautions,"Hemorrhage, bleeding, Grade 3 or higher bleeding events, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, Fatal bleeding events, Infections, fever, Grade 3 or greater infections, progressive multifocal leukoencephalopathy (PML), Cytopenias, neutropenia, thrombocytopenia, anemia, Atrial Fibrillation, atrial flutter, arrhythmic symptoms, palpitations, lightheadedness, new onset dyspnea, Second Primary Malignancies, non-skin carcinomas, non-melanoma skin cancer, Tumor Lysis Syndrome, Embryo-Fetal Toxicity, fetal harm, malformations, reduced fetal weights."
216,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, eye irritation, headache, increased IOP, limbal and conjunctival hyperemia, anterior chamber flare, dry eye, iridocyclitis"
217,DUREZOL,warnings and precautions,"glaucoma, damage to the optic nerve, defects in visual acuity, defects in fields of vision, posterior subcapsular cataract formation, delayed healing, increase the incidence of bleb formation, corneal or sclera perforations, suppress the host response, increase the hazard of secondary ocular infections, mask infection, enhance existing infection, prolong the course of viral infections, exacerbate the severity of viral infections, fungal infections of the cornea, persistent corneal ulceration"
218,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, increased ALT, increased AST, convulsion, pneumonia, ILD/pneumonitis, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, abdominal pain, upper abdominal pain, abdominal discomfort, epigastric discomfort, dyspepsia, gastroesophageal reflux disease, dysphagia, asthenia, maculopapular rash, acneiform dermatitis, neuropathy, paresthesia, muscular weakness, gait disturbance, peripheral neuropathy, hypoesthesia, peripheral sensory neuropathy, dysesthesia, neuralgia, peripheral motor neuropathy, hypotonia, polyneuropathy, vision disorder, vision impairment, blurred vision, photopsia, accommodation disorder, presbyopia, reduced visual acuity, Hemoglobin decreased, Alanine transaminase (ALT) increased, Aspartate transaminase (AST) increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin (total) increased"
219,ZYKADIA,warnings and precautions,"diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, elevated transaminases, jaundice, Interstitial Lung Disease (ILD), Pneumonitis, QT Interval Prolongation, ventricular tachyarrhythmias, Torsade de pointes, sudden death, Hyperglycemia, Bradycardia, Pancreatitis, fetal harm, skeletal anomalies"
220,CHOLINE,adverse reactions,mild injection site reaction
221,CHOLINE,warnings and precautions,"Imaging errors, blood PSA levels < 2 ng/mL associated with poor imaging performance, allergic reactions, anaphylaxis, radiation risk, increased risk for cancer, false positive 11 C-choline PET images, false negative results, tissue inflammation associated with false positive 11 C-choline PET images, prostatic hyperplasia associated with false positive 11 C-choline PET images, interference of concomitant colchicine with 11 C-choline PET imaging, interference of androgen-deprivation therapeutic drugs with 11 C-choline PET imaging"
222,ERWINAZE,adverse reactions,"Hypersensitivity reactions, Pancreatitis, Glucose intolerance, Thrombosis and hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, thrombosis, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, hyperlipidemia, ketoacidosis, CNS events, hemorrhagic events, hepatobiliary disorders, pancreatic disorders, hypersensitivity reaction, anti-drug antibodies (ADA)"
223,ERWINAZE,warnings and precautions,"Serious hypersensitivity reactions, anaphylaxis, Severe pancreatitis, hemorrhagic pancreatitis, Glucose intolerance, hyperglycemia, Thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
224,SAPHRIS,adverse reactions,"Use in Elderly Patients with Dementia-Related Psychosis, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hypersensitivity Reactions, Application site reactions including oral ulcers, blisters, peeling/sloughing and inflammation, Orthostatic Hypotension, Syncope, and other Hemodynamic Effects, Leukopenia, Neutropenia, and Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Potential for Cognitive and Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms other than akathisia, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, Constipation, Dry mouth, Salivary hypersecretion, Stomach discomfort, Vomiting, Irritability, Increased weight, Increased appetite, Extrapyramidal symptoms (excluding akathisia), Insomnia, Hypertension, Anxiety, Toothache, Arthralgia, Pain in extremity, Headache, Depression, Tachycardia, Glossodynia, Edema peripheral, Dysmenorrhea, Oropharyngeal pain, Nasal congestion, Dyspnea, Rash, Parkinsonism, Suicidal ideation, Anger, anemia, thrombocytopenia, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, Choking, oropharyngeal muscular dysfunction, hypoesthesia."
225,SAPHRIS,boxed warnings,increased mortality in elderly patients with dementia-related psychosis
226,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, hyperglycemia, dyslipidemia, weight gain, anaphylaxis, angioedema, Orthostatic Hypotension, Syncope, Dizziness, tachycardia, bradycardia, Leukopenia, Neutropenia, Agranulocytosis, QT Prolongation, Seizures, Cognitive and Motor Impairment, Suicide, increased mortality, heart failure, sudden death, pneumonia, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure changes, diaphoresis, cardiac dysrhythmia, elevated creatine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, central anticholinergic toxicity, heat stroke, drug fever, primary central nervous system pathology, involuntary dyskinetic movements, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, hypersomnia, somnolence, sedation, pyrexia, feeling hot, dysphagia, aspiration pneumonia, myocardial infarction, unstable heart disease"
227,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash"
228,CARBAGLU,warnings and precautions,"Hyperammonemia, injury to the brain, death, acute symptomatic hyperammonemia, brain injury/damage"
229,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, cataract, serum liver test abnormalities, hepatobiliary laboratory abnormalities, portal vein thromboses, abdominal pain, toothache, AST increased, vitamin D deficiency, ALT increased, pain in extremity, dyspnea, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, cytogenetic abnormalities, Thrombotic microangiopathy with acute renal failure."
230,PROMACTA,boxed warnings,hepatic decompensation
231,PROMACTA,warnings and precautions,"hepatotoxicity, liver function abnormalities, liver enzyme elevations, indirect hyperbilirubinemia, increased direct bilirubin, clinical symptoms of liver injury, hepatic decompensation, thrombotic event, thrombotic/thromboembolic complications, venous and arterial events, portal vein thrombosis, abdominal pain, nausea, vomiting, diarrhea, cataracts, worsened cataracts"
232,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
233,BESIVANCE,warnings and precautions,"Growth of Resistant Organisms with Prolonged Use, overgrowth of non-susceptible organisms, including fungi, super-infection"
234,INLYTA,adverse reactions,"diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, lipase increased, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia"
235,INLYTA,warnings and precautions,"hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula, hypothyroidism, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), proteinuria, liver enzyme elevation, fetal harm"
236,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia and Confusion, exacerbate existing ischemic heart disease, arrhythmias, congestive heart failure, Headache, dizziness, nausea, hypertension, fatigue, falls, urinary tract infections, syncope"
237,NORTHERA,boxed warnings,supine hypertension
238,NORTHERA,warnings and precautions,"supine hypertension, cardiovascular risk, Hyperpyrexia, confusion, exacerbate symptoms in patients with existing ischemic heart disease, arrhythmias, congestive heart failure, Allergic reactions, neuroleptic malignant syndrome (NMS), fever or hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, exacerbate existing ischemic heart disease, exacerbate arrhythmias, exacerbate congestive heart failure, allergic-type reactions, bronchial asthma"
239,ADCETRIS,all-concat,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity in the Presence of Severe Renal Impairment, Increased Toxicity in the Presence of Moderate or Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, Toxic epidermal necrolysis, Stevens-Johnson syndrome, tumor lysis syndrome, pneumonia, bacteremia, sepsis, septic shock, pulmonary embolism, pneumonitis, pneumothorax, pyelonephritis, septic shock, supraventricular arrhythmia, urinary tract infection, PML, hepatotoxicity, serious infections, opportunistic infections, embryo-fetal toxicity."
240,ADREVIEW,all-concat,"Serious hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising, Hypersensitivity reactions, anaphylactic and hypersensitivity treatment measures, serious reactions in premature or low birth-weight infants, increased radiation exposure, decreased quality of AdreView images, toxicity (hypotension, metabolic acidosis), kernicterus, deaths in preterm infants, increased long term risk for thyroid neoplasia, transient episode of hypertension"
241,AFINITOR,all-concat,"Non-infectious pneumonitis, Infections, Angioedema with concomitant use of ACE inhibitors, Oral ulceration, Renal failure, Impaired wound healing, Stomatitis, Rash, Fatigue, Diarrhea, Edema, Abdominal pain, Nausea, Fever, Asthenia, Cough, Headache, Decreased appetite, Hypercholesterolemia, Hyperglycemia, Increased aspartate transaminase (AST), Anemia, Leukopenia, Thrombocytopenia, Lymphopenia, Increased alanine transaminase (ALT), Hypertriglyceridemia, Dyspnea, Pneumonitis, Vomiting, Constipation, Dry mouth, Pyrexia, Weight decreased, Arthralgia, Back pain, Pain in extremity, Dysgeusia, Insomnia, Epistaxis, Pruritus, Alopecia, Hot flush, Hemoglobin decreased, WBC decreased, Platelets decreased, Glucose increased, Cholesterol increased, Triglycerides increased, Albumin decreased, Potassium decreased, Creatinine increased, Alkaline phosphatase increased, Bicarbonate decreased, Phosphate decreased, Calcium decreased, Sodium decreased, Bilirubin increased, Potassium increased, Acute renal failure, Acute respiratory distress, Cardiac arrest, Death (cause unknown), Hepatic failure, Pneumonia, Sepsis, Pulmonary embolism, Hypoglycemia, Myocardial infarction, Congestive heart failure, Sudden death, Renal failure, Thrombotic events, Pulmonary embolus, Thrombosis, Amenorrhea, Menorrhagia, Menstrual irregularities, Vaginal hemorrhage, Epistaxis, Otitis media, Depression, Abnormal taste, Increased blood luteinizing hormone (LH) levels, Increased blood follicle stimulating hormone (FSH) levels, Hypersensitivity, Ovarian cyst, Angioedema, Elevated partial thromboplastin time, Neutropenia, Elevated aspartate transaminase (AST), Elevated alanine transaminase (ALT), Hypertriglyceridemia, Hypophosphatemia, Pyrexia, Gastroenteritis, Aggression, Agitation, Rash, Acne, Abdominal pain, Dysgeusia, Dizziness, Paresthesia, Eyelid edema, Conjunctivitis, Hypertension, Deep vein thrombosis, Renal failure, Tachycardia, Congestive cardiac failure, Jaw pain, Hemorrhage, Acute pancreatitis, Cholecystitis, Cholelithiasis, Arterial thrombotic events, Reflex sympathetic dystrophy, Non-infectious pneumonitis: Monitor for clinical symptoms or radiological changes; fatal cases have occurred, Infections: Increased risk of infections, some fatal, Angioedema: Patients taking concomitant ACE inhibitor therapy may be at increased risk for angioedema, Oral ulceration: Mouth ulcers, stomatitis, and oral mucositis are common, Renal failure: Cases of renal failure (including acute renal failure), some with a fatal outcome, have been observed, Impaired wound healing: Increased risk of wound-related complications, Laboratory test alterations: Elevations of serum creatinine, urinary protein, blood glucose, and lipids may occur, Decreases in hemoglobin, neutrophils, and platelets may also occur, Vaccinations: Avoid live vaccines and close contact with those who have received live vaccines, Embryo-fetal toxicity: Fetal harm can occur when administered to a pregnant woman."
242,AMPYRA,all-concat,"Seizures, Anaphylaxis, Urinary Tract Infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, treatment emergent adverse events leading to discontinuation, confusional state, dose-dependent increase in the incidence of seizures, severe allergic reactions, respiratory compromise, urticaria, angioedema of the throat and or tongue"
243,AMYVID,all-concat,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing, image interpretation errors, radiation risk"
244,APTIOM,all-concat,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions and Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, asthenia, gait disturbance, peripheral edema, urinary tract infections, fall, hyponatremia, balance disorder, dysarthria, memory impairment, nystagmus, depression, insomnia, cough, rash, hypertension, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, laryngeal edema, seizures, severe nausea/vomiting, dehydration, severe gait instability, injury, malaise, lethargy, confusion, irritability, muscle weakness/spasms, obtundation, increase in seizure frequency or severity, disturbance in gait and coordination, balance disorder, nystagmus, abnormal coordination, hypersomnia, sedation, lethargy, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, impaired vision, visual impairment, diarrhea, constipation, abdominal pain, gastritis, mild to moderate elevations in transaminases, elevations of total bilirubin, decreases in serum T3 and T4 (free and total)."
245,ARCAPTA,all-concat,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia/heart rate increase/palpitations, pruritus/rash, dizziness, cardiovascular effects, fatalities, immediate hypersensitivity reactions, life-threatening paradoxical bronchospasm, clinically significant cardiovascular effect, increases in pulse rate, systolic or diastolic blood pressure, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, hypokalemia, hyperglycemia"
246,BELEODAQ,all-concat,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, Constipation, Diarrhea, Dyspnea, Rash, Peripheral Edema, Cough, Thrombocytopenia, Pruritus, Chills, Increased Blood Lactate Dehydrogenase, Decreased Appetite, Headache, Infusion Site Pain, Hypokalemia, Prolonged QT, Abdominal pain, Hypotension, Phlebitis, Dizziness, pneumonia, increased creatinine, multi-organ failure, hepatic failure, ventricular fibrillation, febrile neutropenia, leukopenia (neutropenia and lymphopenia), sepsis, liver function test abnormalities, teratogenicity, embryo-fetal lethality"
247,BENLYSTA,all-concat,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions including Anaphylaxis, Infusion Reactions, Depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, Fatal anaphylaxis, Progressive Multifocal Leukoencephalopathy (PML), upper respiratory tract infection, urinary tract infection, sinusitis, influenza, pneumonia, cellulitis, infections leading to discontinuation of treatment, infections resulting in death, malignancies including non-melanoma skin cancers, acute hypersensitivity reactions, death, non-acute hypersensitivity reactions including rash, nausea, fatigue, myalgia, headache, facial edema, Anaphylaxis, hypotension, angioedema, urticaria or other rash, pruritus, dyspnea, serious infusion reactions excluding hypersensitivity reactions, bradycardia, myalgia, headache, rash, urticaria, hypotension, psychiatric events, depression-related events, insomnia, anxiety, serious psychiatric events, serious depression, suicides, live vaccines, secondary transmission of infection, new immunizations, concomitant use with other biologic therapies or intravenous cyclophosphamide."
248,BEPREVE,all-concat,"mild taste following instillation, eye irritation, headache, nasopharyngitis, itching, body rash, swelling of lips, tongue and/or throat"
249,BESIVANCE,all-concat,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
250,BLINCYTO,all-concat,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, febrile neutropenia, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, infection, overdose, confusion, Staphylococcal bacteremia, Anemia, Thrombocytopenia, Leukopenia, Diarrhea, Abdominal pain, Vomiting, Fatigue, Chills, Chest pain, Cytokine release syndrome, Other pathogen infections, Bacterial infections, Fungal infections, Viral infections, Increased alanine aminotransferase, Increased aspartate aminotransferase, Increased weight, Hypomagnesemia, Hyperglycemia, Decreased appetite, Hypophosphatemia, Back pain, Pain in extremity, Bone pain, Arthralgia, Dizziness, Insomnia, Cough, Dyspnea, Hypotension, Hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, capillary leak syndrome, hypersensitivity, bronchospasm, asthenia, disseminated intravascular coagulation (DIC), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), disturbances in consciousness, coordination and balance disorders, opportunistic infections, catheter-site infections, seizures, transient elevations in liver enzymes, leukoencephalopathy."
251,BOSULIF,all-concat,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, Diarrhea (82%), nausea (46%), thrombocytopenia (41%), vomiting (39%), abdominal pain (37%), rash (35%), anemia (27%), pyrexia (26%), fatigue (24%), Increased alanine aminotransferase, Headache, Cough, Increased aspartate aminotransferase, Neutropenia, Edema, Arthralgia, Decreased appetite, Respiratory tract infection, Nasopharyngitis, Back pain, Asthenia, Pruritus, Dizziness, Dyspnea, QTcF interval of greater than 500 milliseconds, Platelet Count (Low), Absolute Neutrophil Count (Low), Hemoglobin (Low), SGPT/ALT greater than 5.0*ULN, SGOT/AST greater than 5.0*ULN, Lipase greater than 2*ULN, Phosphorus (Low), Total Bilirubin greater than 3.0*ULN, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, abnormal hepatic function, liver injury, drug hypersensitivity, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, erythema multiforme, exfoliative rash, drug eruption."
252,BREO,all-concat,"asthma-related death, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism and adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, influenza, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, bronchitis, sinusitis, cough, oropharyngeal pain, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, pharyngitis, pyrexia, arthralgia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, pharyngitis, rhinitis, arthralgia, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, pneumonia, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, asthma-related hospitalizations, paradoxical bronchospasm, adrenal insufficiency, worsening of infections, tuberculosis, fungal infections, bacterial infections, viral infections, parasitic infections, ocular herpes simplex, chickenpox, measles, electrolyte loss, systemic corticosteroid withdrawal symptoms, joint and/or muscular pain, lassitude, depression, allergic conditions, rhinitis, conjunctivitis, eczema, arthritis, eosinophilic conditions, cardiovascular effects, pulse rate increases, systolic blood pressure increases, diastolic blood pressure increases, cardiac arrhythmias, supraventricular tachycardia, extrasystoles, electrocardiographic changes, T wave flattening, QTc interval prolongation, ST segment depression, glaucoma, increased intraocular pressure, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, growth velocity reduction in children and adolescents."
253,CARBAGLU,all-concat,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash, hyperammonemia, brain injury/damage, death"
254,CERDELGA,all-concat,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, ECG changes, cardiac arrhythmias, prolongation of the PR, QTc, and/or QRS cardiac intervals"
255,CHOLINE,all-concat,"mild injection site reaction, Imaging errors, allergic reactions, anaphylaxis, increased risk for cancer"
256,CIMZIA,all-concat,"upper respiratory tract infection, rash, urinary tract infection, Serious Infections, Malignancies, Heart Failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, Anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, Angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, Optic neuritis, retinal hemorrhage, uveitis, Bleeding, injection site reactions, Elevated liver enzymes, hepatitis, Alopecia totalis, Anxiety, bipolar disorder, suicide attempt, Nephrotic syndrome, renal failure, Menstrual disorder, Dermatitis, erythema nodosum, Thrombophlebitis, vasculitis, Headache, Hypertension, Back pain, Pharyngitis, Acute bronchitis, Fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis, Active tuberculosis, Invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, Bacterial, viral and other infections due to opportunistic pathogens, Legionella, Listeria, Hepatosplenic T-cell lymphoma, acute and chronic leukemia, Anaphylaxis, serious allergic reactions, Hepatitis B virus reactivation, Demyelinating disease, Cytopenias, Lupus-like syndrome, Immunogenicity, Hypersensitivity Reactions, angioedema, dermatitis allergic, dizziness (postural), dyspnea, hot flush, hypotension, malaise, serum sickness, (vasovagal) syncope"
257,CLEVIPREX,all-concat,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation, negative inotropic effects, exacerbate heart failure, rebound hypertension"
258,COARTEM,all-concat,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, hypersensitivity reactions, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, nasopharyngitis, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, malaria, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, aspartate aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption), QT prolongation, congenital prolongation of the QT interval, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, disturbances of electrolyte balance, hypokalemia, hypomagnesemia, recrudescence"
259,COMETRIQ,all-concat,"Perforations and Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, fistulas, cardiac arrest, respiratory failure, unspecified death, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone (TSH), Gastrointestinal perforations, fistula formation, hemorrhage including hemoptysis and gastrointestinal hemorrhage, myocardial infarction, cerebral infarction, arterial thromboembolic events, dehiscence, hypertensive crisis, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, slow healing of the mouth or jaw after dental surgery, intolerable Grade 2 PPES, Grade 3-4 PPES, nephrotic syndrome, seizures, headache, visual disturbances, confusion, altered mental function, embryolethal, skeletal variations, visceral variations, malformations"
260,DALVANCE,all-concat,"nausea (5.5%), headache (4.7%), diarrhea (4.4%), vomiting (2.8%), rash (2.7%), pruritus (2.1%), anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, ALT elevations, serious hypersensitivity (anaphylactic) and skin reactions, ""Red-Man Syndrome,"" Clostridium difficile-associated diarrhea (CDAD)"
261,DATSCAN,all-concat,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, skin erythema, injection site pain"
262,DIFICID,all-concat,"nausea (11%), vomiting (7%), abdominal pain (6%), gastrointestinal hemorrhage (4%), anemia (2%), neutropenia (2%), vomiting (0.5%), anemia (2%), neutropenia (2%), nausea (11%), vomiting (7%), abdominal pain (6%), gastrointestinal hemorrhage (4%), abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions (dyspnea, angioedema, rash, and pruritus), acute hypersensitivity reactions (angioedema, dyspnea, pruritus, and rash)"
263,DOTAREM,all-concat,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis"
264,DUAVEE,all-concat,"muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis (DVT), gallbladder disease, hypertriglyceridemia, loss of vision, high blood pressure, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems such as asthma, diabetes, epilepsy, migraines, a genetic problem called porphyria, lupus and liver problems, blood clots, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, dementia, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems such as asthma, diabetes, epilepsy, migraines, a genetic problem called porphyria, lupus and liver problems, new breast lumps, unusual vaginal bleeding, changes in vision or speech, sudden new severe headaches, severe pains in your chest or legs with or without shortness of breath, weakness and fatigue, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain, blood clots, stroke, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, dementia, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems such as asthma, diabetes, epilepsy, migraines, a genetic problem called porphyria, lupus and liver problems, currently have or have had blood clots, currently have or have had certain cancers, currently have or have had liver problems, have been diagnosed with a bleeding disorder, unusual vaginal bleeding, cardiovascular disorders, including venous thromboembolism, pulmonary embolism, stroke, and retinal vascular thrombosis, malignant neoplasms, including endometrial cancer, breast cancer, and ovarian cancer, gallbladder disease, hypertriglyceridemia, cholestatic jaundice, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of other conditions such as asthma, diabetes, epilepsy, migraine or porphyria, systemic lupus erythematosus, hepatic hemangiomas, increased thyroid-binding globulin (TBG), impaired glucose tolerance."
265,DUREZOL,all-concat,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal and conjunctival hyperemia, dry eye, iridocyclitis, glaucoma, defects in visual acuity and fields of vision, posterior subcapsular cataract formation, delayed healing, bleb formation, bacterial infections, viral infections, fungal infections"
266,DYSPORT,all-concat,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia and Breathing Difficulties, Facial Anatomy in the Treatment of Glabellar Lines, Pre-existing Neuromuscular Disorders, Human Albumin, Intradermal Immune Reaction, muscular weakness, dysphagia, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, blurred vision, diplopia, reduced visual acuity and accommodation, breathing difficulties, dyspnea, muscle atrophy, blood glucose increase, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site reaction, eyelid ptosis, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, erythema, excessive granulation tissue, immunogenicity, antibodies formation, botulinum toxin effects, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, respiratory failure, aspiration, muscle atrophy, sensation of heaviness, gait disturbance, hypertonia."
267,EDARBI,all-concat,"diarrhea, hypotension/orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, high markedly abnormal platelet counts, high markedly abnormal WBC counts, rash, pruritus, angioedema, fetal toxicity, injury and death to the developing fetus, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, neonatal hypotension, neonatal renal failure, neonatal death, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure"
268,ELIQUIS,all-concat,"Increased risk of thrombotic events after premature discontinuation, Bleeding, Spinal/epidural anesthesia or puncture, Most common adverse reactions (>1%) are related to bleeding, The most common reason for treatment discontinuation in both studies was for bleeding-related adverse reactions, Major bleeding, Intracranial bleed, Hemorrhagic stroke, Gastrointestinal (GI) bleed, Fatal bleeding, Intracranial, Non-intracranial, Hypersensitivity reactions, Anaphylactic reactions, Syncope, Adverse reactions, Bleeding results during the treatment period, Major (including surgical site), Fatal, Hgb decrease >=2 g/dL, Transfusion of >=2 units RBC, Bleed at critical site, Major+ CRNM, All, Nausea, Anemia, Contusion, Hemorrhage, Postprocedural hemorrhage, Transaminases increased, Aspartate aminotransferase increased, Gamma-glutamyltransferase increased, Thrombocytopenia, Hypotension, Epistaxis, Gastrointestinal hemorrhage, Hematochezia, Liver function test abnormal, Blood alkaline phosphatase increased, Blood bilirubin increased, Hematuria, Wound secretion, Incision-site hemorrhage, Operative hemorrhage, Gingival bleeding, Hemoptysis, Hypersensitivity, Muscle hemorrhage, Ocular hemorrhage, Rectal hemorrhage, Hemorrhagic anemia, Hemorrhoidal hemorrhage, Anal hemorrhage, Wound hemorrhage, Postprocedural hemorrhage, Traumatic hematoma, Periorbital hematoma, Muscle hemorrhage, Vaginal hemorrhage, Metrorrhagia, Menometrorrhagia, Genital hemorrhage, Hemorrhage, Ecchymosis, Skin hemorrhage, Petechiae, Conjunctival hemorrhage, Retinal hemorrhage, Eye hemorrhage, Blood urine present, Occult blood positive, Occult blood, Red blood cells urine positive, Injection-site hematoma, Vessel puncture-site hematoma, Premature discontinuation of ELIQUIS increases the risk of thrombotic events, SPINAL/EPIDURAL HEMATOMA, ELIQUIS can cause serious, potentially fatal bleeding, Prosthetic heart valves: ELIQUIS use not recommended, Increased Risk of Thrombotic Events after Premature Discontinuation, Bleeding, Spinal/Epidural Anesthesia or Puncture, Patients with Prosthetic Heart Valves, Acute PE in Hemodynamically Unstable Patients or Patients who Require Thrombolysis or Pulmonary Embolectomy"
269,ENTEREG,all-concat,"dyspepsia, myocardial infarction, abdominal pain, nausea and vomiting, diarrhea"
270,EOVIST,all-concat,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, elevation of serum bilirubin laboratory values, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness, acute kidney injury, extravasation, myocyte necrosis and inflammation, falsely high or low serum iron values, reduced hepatic contrast."
271,ERWINAZE,all-concat,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, hyperlipidemia, ketoacidosis, CNS events, cerebral venous thrombosis, anti-drug antibodies (ADA), anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, sagittal sinus thrombosis, pulmonary embolism, fibrinogen decreased, protein C activity decreased, protein S activity decreased, anti-thrombin III decreased"
272,EYLEA,all-concat,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, intraocular pressure increased, vitreous detachment, Ocular hyperemia, Corneal epithelium defect, Detachment of the retinal pigment epithelium, Injection site pain, Foreign body sensation in eyes, Lacrimation increased, Vision blurred, Intraocular inflammation, Retinal pigment epithelium tear, Injection site hemorrhage, Eyelid edema, Corneal edema, hypersensitivity, retinal tear, endophthalmitis, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death"
273,FANAPT,all-concat,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, vision blurred, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, anemia, iron deficiency anemia, leukopenia, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation, increased mortality in elderly patients with dementia-related psychosis, cerebrovascular adverse events including stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, hyperglycemia, diabetes mellitus, dyslipidemia, seizures, leukopenia, neutropenia, agranulocytosis, hyperprolactinemia, body temperature regulation disruption, dysphagia, suicide, priapism, cognitive and motor impairment"
274,FARXIGA,all-concat,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, female genital mycotic infections, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, angioedema, urticaria, hypersensitivity, anaphylactic reactions, severe cutaneous adverse reactions, increases in hematocrit, hyperphosphatemia, increases in serum inorganic phosphorus, increases in serum creatinine, decreases in eGFR, vulvovaginal mycotic infection, vaginal infection, vulvovaginal candidiasis, vulvovaginitis, genital infection, genital candidiasis, fungal genital infection, vulvitis, genitourinary tract infection, vulval abscess, vaginitis bacterial, cystitis, Escherichia urinary tract infection, pyelonephritis, trigonitis, urethritis, kidney infection, prostatitis, pollakiuria, polyuria, urine output increased, balanitis, balanitis candida, genital infection male, penile infection, balanoposthitis, balanoposthitis infective, posthitis, major hypoglycemia, minor hypoglycemia."
275,FERRIPROX,all-concat,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, Neutrophil count decreased, Weight increased, Aspartate Aminotransferase increased, Increased appetite, Decreased appetite, Back pain, Pain in extremity, Arthropathy, Headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
276,FIRAZYR,all-concat,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache, anti-icatibant antibodies, hypersensitivity, anaphylactic reactions"
277,FULYZAQ,all-concat,"Upper respiratory tract infection, Bronchitis, Cough, Flatulence, Increased bilirubin, Nausea, Back pain, Arthralgia, Urinary tract infection, Nasopharyngitis, Musculoskeletal pain, Hemorrhoids, Giardiasis, Anxiety, Increased alanine aminotransferase, Abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
278,GADAVIST,all-concat,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash (includes generalized, macular, papular, pruritic), Pruritus (includes generalized), Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, acute kidney injury"
279,GILENYA,all-concat,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, Influenza, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, dizziness, pneumonia, eczema, pruritus, ischemic and hemorrhagic strokes, peripheral arterial occlusive disease, lymphoma, bradyarrhythmia, hypotension, fatigue, palpitations, chest pain, transient AV conduction delays, first-degree AV block, second-degree AV blocks, Mobitz Types I, 2:1 AV blocks, third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, syncope, dose-dependent reduction in peripheral lymphocyte count, bronchitis, herpes zoster, pneumonia, Herpes Viral Infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, Cryptococcal infections, cryptococcal meningitis, Varicella Zoster Virus Antibody Testing/Vaccination, Progressive Multifocal Leukoencephalopathy, PML, JC virus, JCV, macular edema, blurred vision, decreased visual acuity, visual disturbances, dose-dependent reductions in forced expiratory volume over 1 second (FEV1), diffusion lung capacity for carbon monoxide (DLCO), unexplained dyspnea, elevation of liver transaminases, jaundice, dark urine, Fetal Risk, Blood Pressure Effects, hypertension, Immune System Effects Following GILENYA Discontinuation."
280,GILOTRIF,all-concat,"Diarrhea, Bullous and Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, Cheilitis, Cystitis, Epistaxis, Rhinorrhea, Weight Decreased, Pyrexia, Conjunctivitis, Alanine aminotransferase increased, Hypokalemia, Aspartate aminotransferase increased, Pancreatitis, dehydration, renal failure, bullous, blistering, exfoliating lesions, lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, liver test abnormalities, acute or worsening eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, embryotoxic, abortions."
281,GRANIX,all-concat,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Use in Patients with Sickle Cell Disease, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, anaphylaxis, severe sickle cell crises, hypotension, hypoalbuminemia, edema, hemoconcentration"
282,HALAVEN,all-concat,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, headache, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, embryo-fetal toxicity, QT prolongation"
283,HORIZANT,all-concat,"Somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase, driving impairment, suicidal thoughts or behaviors, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, withdrawal seizure, pancreatic acinar cell adenoma and carcinoma, insomnia, asthenia, confusional state, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, withdrawal seizure, tumorigenic potential"
284,ILARIS,all-concat,"infections, upper respiratory tract infections, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, pharyngitis, tonsillitis, sinusitis, urinary tract infection, viral infection, abdominal pain (upper), injection site reaction (mild), injection site reaction (moderate), hypersensitivity reactions, decreased white blood cells, neutrophils, platelets, decreased white blood cell counts, transient decreases in absolute neutrophil count, mild and transient decreases in platelet counts, elevations of transaminases, high ALT and/or AST, asymptomatic and mild elevations of serum bilirubin, tuberculosis, latent tuberculosis infection, malignancies, anaphylactic reactions, immunosuppression, macrophage activation syndrome (MAS)."
285,IMBRUVICA,all-concat,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, renal failure, stomatitis, dyspepsia, sinusitis, skin infections, pyrexia, asthenia, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, hyperuricemia, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, uric acid levels elevated, hypersensitivity reactions, anaphylactic shock (fatal), urticaria, angioedema, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, petechiae, progressive multifocal leukoencephalopathy (PML), oropharyngeal pain, peripheral neuropathy, second malignancies, laceration, anxiety, insomnia, hypertension, contusion, vision blurred, arthropathy, pruritus, skin cancer, embryo-fetal toxicity, malformations in animals, reduced fetal weights."
286,INLYTA,all-concat,"hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation and fistula formation, thyroid dysfunction, wound healing complications, RPLS, proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hypertensive crisis, cerebrovascular accident, myocardial infarction, retinal artery occlusion, cerebral hemorrhage, lower gastrointestinal hemorrhage, melena, gastric hemorrhage, reversible posterior leukoencephalopathy syndrome (RPLS), hemoglobin decreased, lymphocytes decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia"
287,INTELENCE,all-concat,"Severe skin and hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS, hepatic failure, rhabdomyolysis, fatal cases of toxic epidermal necrolysis, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response to indolent or residual opportunistic infections, autoimmune disorders (such as Graves' disease, polymyositis, and Guillain-Barre syndrome)."
288,INVOKANA,all-concat,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), female genital mycotic infections, urinary tract infection, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy (i.e., asthenia), pancreatitis (acute or chronic), erythema, rash, pruritus, urticaria, angioedema, photosensitivity reaction, polymorphic light eruption, sunburn, hypotension, postural dizziness, orthostatic hypotension, syncope, dehydration, falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, vulvovaginal mycotic infection, vulvovaginal candidiasis, vulvovaginitis, candidal balanitis, balanoposthitis, phimosis, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in hemoglobin, decreases in Bone Mineral Density (BMD), increases in non-High-Density Lipoprotein Cholesterol (non-HDL-C)."
289,JARDIANCE,all-concat,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), urinary tract infections, female genital mycotic infections, Upper respiratory tract infection, Increased urination, Dyslipidemia, Arthralgia, Male genital mycotic infections, Nausea, Thirst (including polydipsia), Volume Depletion, blood pressure (ambulatory) decreased, blood pressure systolic decreased, dehydration, hypovolemia, orthostatic hypotension, syncope, polyuria, pollakiuria, nocturia, serum creatinine increases, eGFR decreases, Hypoglycemia, Overall hypoglycemic events, Severe hypoglycemic events, vaginal mycotic infection, vaginal infection, genital infection fungal, vulvovaginal candidiasis, vulvitis, Phimosis, urinary tract infection, asymptomatic bacteriuria, cystitis, Increase in Hematocrit."
290,JEVTANA,all-concat,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Use in Elderly Patients, Use in Patients with Hepatic Impairment, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, dose reductions, dose delays, Arrhythmia, Dyspepsia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, sepsis, septic shock, neutropenic deaths, generalized rash/erythema, bronchospasm, increased AST, increased ALT, increased bilirubin, Gastritis, intestinal obstruction, gastrointestinal hemorrhage, perforation, neutropenic enterocolitis, ileus, enterocolitis, renal failure with fatal outcomes, obstructive uropathy, severe hypersensitivity reactions, embryotoxic, fetotoxic, abortifacient."
291,JUBLIA,all-concat,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
292,KALBITOR,all-concat,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, antibodies to KALBITOR, seroconversion, anti-ecallantide antibodies, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies, chest discomfort, flushing, pharyngeal edema, rhinorrhea, sneezing, nasal congestion, throat irritation, wheezing, hypotension, rash"
293,KALYDECO,all-concat,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, aspartate aminotransferase increased, blood glucose increased, hepatic enzyme increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, non-congenital lens opacities/cataracts"
294,KYPROLIS,all-concat,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity and Hepatic Failure, Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, myocardial infarction, upper respiratory tract infection, constipation, nausea, fatigue, pyrexia, edema peripheral, asthenia, nasopharyngitis, bronchitis, hypokalemia, hypocalcemia, hyperglycemia, muscle spasms, peripheral neuropathies NEC, insomnia, cough, dyspnea, rash, embolic and thrombotic events, venous, hypertension, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, dehydration, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, tumor lysis syndrome, cardiac failure, myocardial infarction, myocardial ischemia, Acute Respiratory Distress Syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pulmonary arterial hypertension, hypertensive crisis, hypertensive emergency, venous thromboembolic events, deep venous thrombosis, pulmonary embolism, fever, chills, arthralgia, myalgia, facial flushing, facial edema, vomiting, weakness, shortness of breath, syncope, chest tightness, angina, hepatic failure, embryo-fetal toxicity."
295,LUMIZYME,all-concat,"anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, chest pain/discomfort, supraventricular tachycardia, paresthesia, local swelling, diarrhea, pruritus, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, flu-like illness, arthralgia, pain, bradycardia, bronchospasm, hypotension, face edema, chest discomfort/pain, peripheral coldness, convulsions, pruritus, rash, hyperhidrosis, hypertension/increased blood pressure, flushing/feeling hot, erythema, pyrexia, pallor, restlessness, nervousness, headache, back pain, paresthesia, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, hypotension, angioedema, urticaria, chest discomfort/pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension/increased blood pressure, flushing/feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, necrotizing skin lesions, inflammatory arthropathy, elevated erythrocyte sedimentation rate, immune complex deposition, edema, peripheral, rash papular, throat tightness"
296,MULTAQ,all-concat,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, premature discontinuation, gastrointestinal disorders, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, early increases in creatinine >=10%, QTc prolonged, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis, increased risk of death, stroke, heart failure, cardiovascular death, hepatocellular liver injury, acute liver failure, hepatotoxicity, dyspnea, non-productive cough, marked increase in serum creatinine, pre-renal azotemia, acute renal failure, small increases in creatinine levels"
297,NATAZIA,all-concat,"Serious cardiovascular events and stroke, Vascular events, Liver disease, Irregular uterine bleeding, Nausea, Breast tenderness, Headache, headaches, irregular uterine bleeding, headache (including migraines) 13%, breast tenderness, pain 7%, menstrual disorders 7%, nausea/ or vomiting 6%, acne 4%, mood changes 3%, increased weight 3%, menstrual disorder (metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding) 2.3%, mood changes (depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying) 1.2%, acne 1.1%, headache (including migraines) 1.1%, weight increased 0.7%, headache (including migraines) 12.7%, breast pain, discomfort or tenderness 7.0%, menstrual disorders (metrorrhagia, menstruation irregular, menorrhagia, vaginal hemorrhage, dysfunctional uterine bleeding, genital hemorrhage, abnormal withdrawal bleeding, uterine hemorrhage) 6.9%, nausea or vomiting 6.0%, acne 3.9%, mood changes (depression, mood swings, depressed mood, mood altered, affect lability, dysthymic disorder, crying) 3.0%, increased weight 2.9%, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, Venous and arterial thromboembolic events (including pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction and stroke), hypertension, Gallbladder disease, hepatitis, Hypersensitivity, Fluid retention, hypertriglyceridemia, Dizziness, Chloasma, angioedema, erythema nodosum, erythema multiforme, Gastrointestinal symptoms (for example, abdominal pain), Vulvovaginal candidiasis, jaundice, Hepatic adenomas, hepatocellular carcinoma, COC-related cholestasis, increase in blood pressure, Gallbladder disease, decrease in glucose tolerance, adverse lipid changes, hypertriglyceridemia, pancreatitis, new headaches, recurrent, persistent, or severe headaches, increase in frequency or severity of migraine, Breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, intracyclic bleeding, depression, changes in coagulation factors, lipids, glucose tolerance, and binding proteins, increased doses of thyroid hormone, hereditary angioedema, exacerbate symptoms of angioedema, Chloasma."
298,NESINA,all-concat,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
299,NEURACEQ,all-concat,"injection site erythema, injection site irritation, injection site pain"
300,NORTHERA,all-concat,"Supine Hypertension, Hyperpyrexia, Confusion, exacerbate existing ischemic heart disease, arrhythmias, congestive heart failure, Headache, dizziness, nausea, hypertension, fatigue, falls, urinary tract infections, syncope, allergic reactions, fever or hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, FD&C Yellow No. 5 (tartrazine) sensitivity, bronchial asthma"
301,NULOJIX,all-concat,"PTLD, CNS PTLD, other malignancies, Serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion-related reactions, hypotension, hypertension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, infections and infestations, upper respiratory infection, nasopharyngitis, influenza, bronchitis, CMV, polyoma virus, herpes, tuberculosis, CNS infections, bacterial infections, mycobacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, BK virus-associated nephropathy, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety."
302,ONFI,all-concat,"Somnolence or Sedation, Potentiation of Sedation from Concomitant Use with Central Nervous System Depressants, Withdrawal Symptoms, Serious Dermatological Reactions, Physical and Psychological Dependence, Suicidal Behavior and Ideation, constipation, pyrexia, lethargy, drooling, lethargy, somnolence, ataxia, aggression, fatigue, insomnia, Vomiting, Constipation, Dysphagia, Pyrexia, Irritability, Fatigue, Upper respiratory tract infection, Pneumonia, Urinary tract infection, Bronchitis, Decreased appetite, Increased appetite, Somnolence or Sedation, Lethargy, Drooling, Ataxia, Psychomotor hyperactivity, Dysarthria, Aggression, Insomnia, Cough, Anemia, eosinophilia, leukopenia, thrombocytopenia, Diplopia, vision blurred, Abdominal distention, Hypothermia, Hepatic enzyme increased, Muscle spasms, Agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, Urinary retention, Aspiration, respiratory depression, Rash, urticaria, angioedema, facial and lip edema, convulsions, psychosis, hallucinations, behavioral disorder, tremor, anxiety, dysphoria, insomnia, Stevens-Johnson syndrome, toxic epidermal necrolysis"
303,OTEZLA,all-concat,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, depression, suicidal thoughts, suicidal behavior, suicidal ideation, weight decrease between 5%-10% of body weight, weight decrease of >=10% of body weight, serious worsening of psoriasis (rebound), fatigue, insomnia, back pain, frequent bowel movements, bronchitis, tooth abscess, folliculitis, sinus headache"
304,PICATO,all-concat,"local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn, eyelid ptosis, anaphylaxis"
305,POTIGA,all-concat,"Retinal abnormalities, potential vision loss, Urinary retention, Skin discoloration, Neuropsychiatric symptoms, Dizziness, Somnolence, QT interval effect, Suicidal behavior and ideation, Withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, Nausea, Constipation, Dyspepsia, Fatigue, Asthenia, Influenza, Weight increased, Dizziness, Somnolence, Memory impairment, Tremor, Vertigo, Abnormal coordination, Disturbance in attention, Gait disturbance, Aphasia, Dysarthria, Balance disorder, Paresthesia, Amnesia, Dysphasia, Confusional state, Anxiety, Disorientation, Psychotic disorder, Dysuria, Urinary hesitation, Hematuria, Chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, urinary retention, malaise, increased liver enzymes, weight gain, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy."
306,PRADAXA,all-concat,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, diarrhea, dyspepsia, nausea, upper abdominal pain, decrease in hemoglobin of >=2 g/dL, transfusion of >=2 units of packed red blood cells, bleeding at a critical site, fatal outcome, intracranial hemorrhage, intracerebral hemorrhage, subarachnoid hemorrhage, subdural hemorrhage, hemorrhagic stroke, gastrointestinal bleeds, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, symptomatic bleeding in a critical area or organ, intraocular bleeding, intraspinal bleeding, intramuscular bleeding with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, fall in hemoglobin level of 2.0 g/dL, transfusion of 2 or more units of whole blood or red cells, clinical myocardial infarction, abdominal pain upper, abdominal discomfort, epigastric discomfort, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, angioedema, thrombocytopenia, esophageal ulcer, spinal/epidural hematoma, paralysis, thromboembolic events, valve thrombosis, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions requiring intervention for hemodynamic compromise"
307,PRISTIQ,all-concat,"Hypersensitivity, Suicidal Thoughts and Behaviors in Adolescents and Young Adults, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease and Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, vomiting, headache, Blood pressure increased, Dry mouth, Fatigue, Chills, Feeling jittery, Tremor, Disturbance in attention, Nervousness, Abnormal dreams, Urinary hesitation, Yawning, Vision blurred, Mydriasis, Vertigo, Tinnitus, Dysgeusia, Hot flush, Anorgasmia, Libido decreased, Orgasm abnormal, Ejaculation delayed, Erectile dysfunction, Ejaculation disorder, Ejaculation failure, Sexual dysfunction, Tachycardia, Asthenia, Weight increased, liver function test abnormal, blood prolactin increased, Musculoskeletal stiffness, Syncope, convulsion, dystonia, Depersonalization, bruxism, Urinary retention, Rash, alopecia, photosensitivity reaction, angioedema, ischemic cardiac adverse reactions, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, Lipids abnormalities, Proteinuria, Orthostatic hypotension, Stevens-Johnson syndrome, Clinical Worsening/Suicide Risk, agitation, hallucinations, delirium, coma, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, gastrointestinal symptoms, nausea, vomiting, diarrhea, sustained hypertension, progressive dyspnea, cough, chest discomfort"
308,PROLIA,all-concat,"Hypocalcemia, Serious Infections, Dermatologic Adverse Reactions, Osteonecrosis of the Jaw, Atypical Subtrochanteric and Diaphyseal Femoral Fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, constipation, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, pancreatitis, new malignancies, cataracts, Drug-related hypersensitivity reactions, anaphylaxis, facial swelling, erythema, severe symptomatic hypocalcemia, severe bone, joint, muscle pain, Parathyroid Hormone (PTH) elevation, suppression of bone turnover"
309,PROMACTA,all-concat,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, abdominal pain, toothache, vitamin D deficiency, dyspnea, pain in extremity, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, thrombotic microangiopathy with acute renal failure, ascites, encephalopathy, serum liver test abnormalities, liver test abnormalities, portal vein thromboses, cytogenetic abnormality, portal venous system thrombosis, venous and arterial events, Factor V Leiden, ATIII deficiency, antiphospholipid syndrome, chronic liver disease, portal vein thrombosis (PVT), abdominal pain, nausea, vomiting, diarrhea."
310,QUTENZA,all-concat,"Application-Associated Pain, Increase in Blood Pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor, eye and mucous membrane exposure, aerosolization of capsaicin, unintended skin exposure, procedural pain, treatment-related increases in pain"
311,SAPHRIS,all-concat,"Use in Elderly Patients with Dementia-Related Psychosis, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hypersensitivity Reactions, Application site reactions including oral ulcers, blisters, peeling/sloughing and inflammation, Orthostatic Hypotension, Syncope, and other Hemodynamic Effects, Leukopenia, Neutropenia, and Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Potential for Cognitive and Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, Use in Patients with Concomitant Illness, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms other than akathisia, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, insomnia, hypertension, anxiety, depression, pain in extremity, arthralgia, headache, abdominal pain, glossodynia, muscle strain, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, suicidal ideation, anger, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, tachycardia, parkinsonism, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, choking, cerebrovascular adverse events (e.g., stroke, transient ischemic attack), anemia, thrombocytopenia, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, hyperglycemia, dyslipidemia, body weight gain, hyperglycemia and Diabetes Mellitus, Hyperglycemia, Dyslipidemia, Weight Gain, Hypersensitivity Reactions, Orthostatic Hypotension, Syncope, and Other Hemodynamic Effects, Leukopenia, Neutropenia, and Agranulocytosis, QT Prolongation, Hyperprolactinemia, Seizures, Potential for Cognitive and Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, Use in Patients with Concomitant Illness, anaphylaxis, angioedema, hypotension, tachycardia, swollen tongue, dyspnea, wheezing, rash, edema peripheral, dystonia, parkinsonism, oculogyration, tremor, bradykinesia, dyskinesia, dystonia, oromandibular dystonia, muscle contractions involuntary, muscle twitching, musculoskeletal stiffness, protrusion tongue, resting tremor, tremor, galactorrhea, amenorrhea, gynecomastia, impotence, pyrexia, feeling hot, aspiration pneumonia."
312,SIMPONI,all-concat,"Serious Infections, Malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, ALT elevations >= 5 * ULN, ALT elevations >= 3 * ULN, formation of autoantibodies, lupus-like syndrome, newly ANA-positive, newly positive anti-dsDNA antibodies, infusion reaction, antibodies to SIMPONI ARIA, Superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, Alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, Dizziness, paresthesia, Constipation, Melanoma, Serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, Interstitial lung disease, Skin exfoliation, bullous skin reactions, Hepatitis B reactivation, Heart failure, Demyelinating disease, Leukopenia, Pyrexia, Bacterial infections, Neoplasm Benign and Malignant, Immune System Disorders, Respiratory, thoracic and mediastinal disorders, Skin and subcutaneous tissue disorders, Congestive Heart Failure, central nervous system demyelinating disorders, peripheral demyelinating disorders, Hematologic Cytopenias, pancytopenia, aplastic anemia, thrombocytopenia, Vaccinations/Therapeutic Infectious Agents, Live Vaccines, Hypersensitivity Reactions"
313,SIRTURO,all-concat,"Increased mortality, QT Prolongation, Hepatotoxicity, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, Transaminases Increased, Rash, Blood Amylase Increased, aminotransferase elevations, Clinically significant ventricular arrhythmia, A QTcF interval of greater than 500 ms, fatigue, jaundice, dark urine, liver tenderness, hepatomegaly, total bilirubin elevation greater than two times the upper limit of normal, aminotransferase elevations greater than eight times the upper limit of normal, aminotransferase elevations greater than five times the upper limit of normal and persist beyond two weeks"
314,STENDRA,all-concat,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, dizziness, arthralgia, diarrhea, gastroenteritis viral, change in color vision, Non-arteritic anterior ischemic optic neuropathy (NAION), sudden loss of vision, prolonged erection, priapism, sudden decrease or loss of hearing, tinnitus, symptomatic hypotension, dizziness, lightheadedness, fainting, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, headache"
315,STRIBILD,all-concat,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, Ocular icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, Skin discoloration, AST elevation, ALT elevation, Amylase elevation, Creatine Kinase elevation, Hematuria, Bone Mineral Density decrease, fractures, Proteinuria, serum creatinine increase, estimated creatinine clearance decrease, allergic reaction, angioedema, lactic acidosis, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia, Redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
316,TAFINLAR,all-concat,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, Pancreatitis, Hypersensitivity manifesting as bullous rash, Interstitial nephritis, Vision blurred, transient blindness, Stomatitis, Asthenia, Cellulitis, folliculitis, paronychia, rash pustular, Skin papilloma, Palmar-plantar erythrodysesthesia syndrome, hyperhidrosis, Hypertension, Leukopenia, Lymphopenia, Neutropenia, Anemia, Thrombocytopenia, Increased AST, Increased alkaline phosphatase, Increased ALT, Hyperbilirubinemia, Increased GGT, Hyponatremia, Hypoalbuminemia, Hypophosphatemia, Hypokalemia, Increased creatinine, Hypomagnesemia, Hyperkalemia, Hypercalcemia, Hypocalcemia, QT Prolongation, Retinal vein occlusion, Interstitial lung disease, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, cuSCC, non-cutaneous malignancies, KRAS mutation-positive pancreatic adenocarcinoma, recurrent NRAS mutation-positive colorectal carcinoma, head and neck carcinoma, glioblastoma, brain stem hemorrhage, cerebral hemorrhage, gastric hemorrhage, epistaxis, gingival hemorrhage, hematuria, vaginal hemorrhage, hemorrhage intracranial, eye hemorrhage, vitreous hemorrhage, renal failure, renal failure acute, Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, Embryofetal Toxicity."
317,TANZEUM,all-concat,"Risk of Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity Reactions, Renal Impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, anti-albiglutide antibodies, anti-GLP-1 antibodies, antibodies to human albumin, alanine aminotransferase (ALT) increase, Gamma Glutamyltransferase (GGT) Increase, Heart Rate Increase, medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), persistent severe abdominal pain, vomiting, pruritus, rash, dyspnea, acute renal failure, worsening of chronic renal failure, dehydration."
318,TECFIDERA,all-concat,"Anaphylaxis, Angioedema, Progressive multifocal leukoencephalopathy, Lymphopenia, Flushing, Abdominal pain, Diarrhea, Nausea, Vomiting, Pruritus, Rash, Albumin urine present, Erythema, Dyspepsia, Aspartate aminotransferase increased, Eosinophilia, Difficulty breathing, Urticaria, Swelling of the throat and tongue, Progressive weakness on one side of the body, Clumsiness of limbs, Disturbance of vision, Changes in thinking, Memory issues, Confusion, Personality changes"
319,TEFLARO,all-concat,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, serious adverse reactions, Treatment discontinuation due to adverse reactions, hypersensitivity, Diarrhea, Nausea, Constipation, Vomiting, Increased transaminases, Hypokalemia, Rash, Phlebitis, Anemia, Eosinophilia, Neutropenia, Thrombocytopenia, Bradycardia, Palpitations, Abdominal pain, Pyrexia, Hepatitis, Anaphylaxis, Clostridium difficile colitis, Hyperglycemia, Hyperkalemia, Dizziness, Convulsion, Renal failure, Urticaria, Agranulocytosis, Serious hypersensitivity (anaphylactic) reactions, fatal hypersensitivity (anaphylactic) reactions, serious skin reactions, Clostridium difficile-associated diarrhea (CDAD), mild diarrhea, fatal colitis, Seroconversion from a negative to a positive direct Coombs' test result, hemolytic anemia, drug-induced hemolytic anemia, Development of Drug-Resistant Bacteria."
320,TIVICAY,all-concat,"Hypersensitivity reactions, Effects on serum liver biochemistries in patients with hepatitis B or C co-infection, Fat Redistribution, Immune Reconstitution Syndrome, insomnia, fatigue, headache, Treatment-emergent Adverse Drug Reactions, adverse events leading to discontinuation, Insomnia, Depression, Abnormal dreams, Dizziness, Headache, Nausea, Diarrhea, Rash, Fatigue, Vertigo, Grade 1 insomnia, Abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, Hepatitis, Myositis, Suicidal ideation, attempt, behavior, or completion, Renal impairment, Pruritus, ALT abnormalities, AST abnormalities, Creatine kinase abnormalities, Hyperglycemia, Lipase abnormalities, Total neutrophils abnormalities, Cholesterol increase, HDL cholesterol increase, LDL cholesterol increase, Triglycerides increase, elevated ALT, elevated AST, elevated cholesterol, elevated creatine kinase, hyperglycemia, elevated lipase, Grade 3 to 4 treatment-emergent hematology laboratory abnormality, neutropenia, Hepatitis B and/or Hepatitis C Virus Co-infection, Liver chemistry elevations, Increases in serum creatinine, rash, constitutional findings, organ dysfunction, liver injury, worsening or development of transaminase elevations, Redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response to indolent or residual opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, Autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
321,TOVIAZ,all-concat,"dry mouth, constipation, angina, chest pain, gastroenteritis, QT prolongation on ECG, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation"
322,TREANDA,all-concat,"Myelosuppression, Infections, Anaphylaxis and Infusion Reactions, Tumor Lysis Syndrome, Skin Reactions, Other Malignancies, Extravasation injury, pyrexia, nausea, vomiting, fatigue, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, malaise, weakness, dry mouth, somnolence, mucosal inflammation, worsening hypertension, hypertensive crisis, hypersensitivity, nasopharyngitis, infection, herpes simplex, hyperuricemia, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, pneumonia, febrile neutropenia, oral candidiasis, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, dizziness, dysgeusia, insomnia, anxiety, depression, pharyngolaryngeal pain, wheezing, nasal congestion, dry skin, night sweats, hyperhidrosis, hypotension, neutropenic sepsis, diffuse alveolar hemorrhage, opportunistic infection (CMV), sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, phlebitis, pruritus, irritation, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, embryo-fetal toxicity, skeletal and visceral malformations, decreased fetal body weights."
323,TRULICITY,all-concat,"Risk of Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, documented symptomatic hypoglycemia, severe hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, systemic hypersensitivity, severe urticaria, systemic rash, facial edema, lip swelling, injection-site reactions, injection-site rash, erythema, PR Interval Prolongation, first degree AV block, amylase increase, lipase increase, medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), dysphagia, dyspnea, persistent hoarseness, acute renal failure, worsening of chronic renal failure, severe gastrointestinal disease, severe gastroparesis."
324,TUDORZA,all-concat,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate Hypersensitivity Reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
325,ULESFIA,all-concat,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, Skin irritation, scalp irritation, Application site Irritation, Application site anesthesia & hypoesthesia, Pain, Pruritus, Erythema, Pyoderma, Ocular irritation, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation, Neonatal toxicity, gasping syndrome, Eye irritation, Contact dermatitis"
326,ULORIC,all-concat,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure (some fatal), jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, gout flare, cardiovascular thromboembolic events, myocardial infarction, stroke, cardiovascular deaths, non-fatal myocardial infarctions, non-fatal strokes."
327,VICTRELIS,all-concat,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, agranulocytosis, thrombocytopenia, embryofetal toxicity, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis"
328,VIMIZIM,all-concat,"Anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, retching, peripheral edema, back pain, paralysis of limbs, urinary incontinence, fecal incontinence"
329,VIZAMYL,all-concat,"flushing (2%), headache (1%), increased blood pressure (2%), nausea (1%), dizziness (1%), serious hypersensitivity reaction with flushing, dyspnea and chest pressure, hypersensitivity reactions such as flushing and dyspnea"
330,VORAXAZE,all-concat,"Serious allergic reactions, including anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction and failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor"
331,XALKORI,all-concat,"Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, nausea, elevated transaminases, hepatotoxicity, ILD, Electrocardiogram QT prolonged, Bradycardia, Vision disorder, Vomiting, Diarrhea, Constipation, Dyspepsia, Dysphagia, Abdominal pain, Pyrexia, Upper respiratory infection, Weight increased, Pain in extremity, Muscle spasm, Dizziness, Dysgeusia, Headache, neuropathy, rash, renal cyst, ILD, syncope, Neutropenia, Lymphopenia, ALT elevation, AST elevation, Hypophosphatemia, pneumonia, acute respiratory distress syndrome, arrhythmia, dyspnea, pneumonia, pneumonitis, pulmonary embolism, ILD, respiratory failure, sepsis, alanine aminotransferase (ALT) elevation, QTc prolongation, neutropenia, ILD, ALT and AST elevation, dyspnea, pulmonary embolism, Dizziness, Dysgeusia, Syncope, Vision disorder, Electrocardiogram QT prolonged, Bradycardia, Weight decreased, Vomiting, Nausea, Diarrhea, Constipation, Dyspepsia, Upper respiratory infection, Pulmonary embolism, Edema, fatigue, neuropathy, dysesthesia, gait disturbance, hypoesthesia, muscular weakness, neuralgia, peripheral neuropathy, parasthesia, peripheral sensory neuropathy, polyneuropathy, burning sensation in skin, rash, ILD, acute respiratory distress syndrome, ILD, pneumonitis, renal cyst, hepatic failure, Neutropenia, Lymphopenia, ALT elevation, AST elevation, Hypokalemia, Hypophosphatemia, fatal hepatotoxicity, concurrent elevations in ALT or AST, total bilirubin, severe visual loss, optic atrophy, optic nerve disorder, embryotoxicity, fetotoxicity."
332,XEOMIN,all-concat,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphonia, urinary incontinence, corneal exposure, ulceration, ectropion, reduced blinking, persistent epithelial defect, corneal ulceration, VII nerve disorders, narrow angle glaucoma, ecchymosis, ptosis"
333,XIAFLEX,all-concat,"Tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, penile hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, tendon rupture, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin laceration (tear), blood blister, injection site hematoma, injection site swelling, ecchymosis, penile ecchymoses, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, severe injection site hematoma, penile ""popping"" sounds or sensations, allergic reactions, anaphylaxis, IgE-anti-drug antibodies, ecchymosis/contusion, injection site hemorrhage."
334,XTANDI,all-concat,"Seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections or sepsis, fall-related injuries, hypertensive crisis"
335,YERVOY,all-concat,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, intestinal perforation, hepatotoxicity, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash complicated by full thickness dermal ulceration, necrotic, bullous, or hemorrhagic manifestations, Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)"
336,ZERBAXA,all-concat,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, renal failure acute, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, dyspnea, urticaria, venous thrombosis"
337,ZYDELIG,all-concat,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, sepsis, febrile neutropenia, elevated transaminases, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, lymphocyte count decreased, lymphocyte count increased, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, serious allergic reactions, teratogenic effects"
338,ZYKADIA,all-concat,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, increased ALT, increased AST, dose reductions, dose interruptions, serious adverse drug reactions, fatal adverse reactions, Abdominal pain, Esophageal disorder, Fatigue, Rash, Interstitial lung disease/pneumonitis, neuropathy, vision disorder, prolonged QT interval, Hemoglobin decreased, Alanine transaminase (ALT) increased, Aspartate transaminase (AST) increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin (total) increased, dose modification, withhold, dose reduce, permanently discontinue, Drug-induced hepatotoxicity, Elevations in alanine aminotransferase (ALT), Concurrent elevations in ALT and total bilirubin, Severe, life-threatening, or fatal ILD/pneumonitis, pneumonitis, CTCAE Grade 3 or 4 ILD/pneumonitis, fatal ILD/pneumonitis, QTc interval prolongation, increased risk for ventricular tachyarrhythmias, Torsade de pointes, sudden death, QTc interval increase, concentration-dependent increases in the QTc interval, sinus bradycardia, symptomatic bradycardia, life-threatening bradycardia, Pancreatitis, CTCAE Grade 3-4 elevations of lipase and/or amylase, skeletal anomalies in rats and rabbits, fetal harm."
339,ZYTIGA,all-concat,"Hypertension, Hypokalemia, Fluid Retention, Adrenocortical Insufficiency, Hepatotoxicity, fatigue, joint swelling or discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, Muscle discomfort, Dyspepsia, Upper respiratory tract infection, Urinary frequency, Nocturia, Fractures, Arrhythmia, Chest pain or chest discomfort, Cardiac failure, Pyrexia, Groin pain, Constipation, Insomnia, Falls, Nasopharyngitis, Hematuria, Rash, High Total Bilirubin, non-infectious pneumonitis, myopathy, rhabdomyolysis, cardiovascular disease, myocardial ischemia, myocardial infarction, cardiorespiratory arrest, sudden death, Hypernatremia, High Total Bilirubin."
